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ABSTRACT
Several genera of aminoglycoside resistant enteric 
bacteria were isolated from commercial turtle farms. 
Citrobacter freundii and Proteus vulgaris were the most 
prevalent organisms. Gentamicin resistance, measured by 
minimum inhibitory concentrations (MIC), ranged as high as 
100 /Ltg/ml. While resistance to other antibiotics was 
detected in gentamicin-resistant isolates, no correlation was 
observed between antibiotic resistance and plasmid content. 
Spontaneous mutation to gentamicin could not account for the 
high levels of gentamicin resistance found in the original 
isolates.
Regions of chromosomal DNA encoding gentamicin 
resistance of 100 fig/ml were obtained from two Citrobacter 
freundii, two Proteus vulgaris, and two Salmonella 
enteritidis strains. These recombinant plasmids imparted a 
level of gentamicin resistance to Escherichia coli similar to 
that observed in the resistant isolates. The resistance gene 
was located on a 858 base pair DNA fragment. This fragment 
was common to both Citrobacter strains and hybridized with 
chromosomal DNA from several gentamicin-resistant enterics.
The nucleotide sequences of the resistance genes 
obtained from Citrobacter freundii, Proteus vulgaris and 
Salmonella enteritidis shared complete homology.
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The region upstream of the C. freundii resistance gene shared 
only 49% homology with consensus promoter sequences in E. 
coli. The gentamicin resistance gene differed by only 3 
bases from the aacC2 gene of plasmid pWP113a from Klebsiella.
By substrate profiling, the 30,000 dalton protein 
encoded by the C. freundii resistance gene was identified as 
an aminoglycoside-(3)-N-acetyltransferase II. Gentamicin, 
kanamycin, and neomycin acetyltransferase activities of cell 
extracts correlated with the respective resistances against 
these antibiotics. Neither levels of gentamicin resistance 
nor acetyltransferase activities were affected by gene dosage 
or level of transcription. Consistent with the calculated 
codon usage index, the C. freundii acetyltransferase appears 
to be translated at low, constitutive levels. Based on 
aminoglycoside acetyltransferase assays and DNA hybridization 
there may be three different gentamicin resistance genes 
within the turtle population.
INTRODUCTION
The Louisiana turtle farming industry has successfully 
marketed pet turtles of the genus Pseudomys scripta-elegans 
for the past twenty years. Prior to 1975, approximately four 
million hatchlings were sold within the United States and 
overseas (Michael-Marler et al., 1983). These turtles were 
known to carry and excrete Salmonella enteritidis (Rosenstein 
et al., 1965) and several outbreaks of disease due to this 
pathogen in the 1970s were traced to pet turtles. This 
ultimately led to banning of interstate sale of viable turtle 
eggs and turtles smaller than 4 inches. European and Far 
Eastern countries, however, have not restricted importation 
of these pets from the United States, and the foreign market 
continues to flourish. At the time national sales were 
banned, turtle farmers created The National Turtle Farmers 
and Shippers Association, Inc. By instituting new measures 
in egg sanitation and hatching procedures, they planned to 
decrease the overall numbers of enteric organisms in turtle 
eggs (Michael-Marler et al., 1983). They sought to eliminate 
Salmonella spp by using antimicrobial agents to provide a 
safe pet for the existing foreign market, and to eventually 
reverse the ban on sale of turtles in the United States.
The most common means of transmitting salmonellae to 
hatchlings occurs via fecal contamination (Williams, 1968). 
Enteric organisms, such as Salmonella spp, penetrate through
the egg shell and survive in the incubating egg. If these 
bacteria were eliminated, the frequency of egg-transmitted 
diseases would decrease. Several antibiotics were tested in 
turkey egg dipping procedures (Lucas et al., 1970; Saif,
1973). Kanamycin and neomycin were found to have limited 
effectiveness against Salmonella spp. However, antibiotics 
like gentamicin greatly reduced the numbers of these 
organisms. After gentamicin proved successful in the 
elimination of Salmonella spp from naturally and artificially 
infected turkey eggs, it was approved by the Federal Drug 
Administration in 1974 for use in the poultry industry.
Antibiotics were also tested for use in the turtle 
industry. Terramycin and Chloromycetin were found to reduce 
the presence of Salmonella and Arizona spp from naturally 
infected turtle eggs (Siebeling et al., 1975). However, 
gentamicin seemed better suited for industrial use because 
gentamicin dip solutions could be sterilized, filtered, and 
stored without significant loss of antibiotic activity. This 
prompted researchers working with the turtle farmers to 
implement the use of gentamicin in turtle egg sanitation 
(Michael-Marler et al., 1983; Siebeling et al., 1984). 
Procedures were designed to reduce the bacterial numbers in 
twenty-four hour old fertile eggs. Eggs placed in single 
layer trays were washed in warm running water, rinsed in 
Clorox solution and oven dried. Antibiotic treatment of 
these sanitized eggs by the pressure differential egg dip 
method (Michael-Marler et al., 1983) was tested with
3different concentrations of gentamicin. Sanitized turtle 
eggs in concentrated gentamicin solution were placed in a 
pressure cooking device upon which a vacuum (18-2 0 lb/inch2, 
for 10 min) was drawn. Slow release of the vacuum caused 
gentamicin uptake into the egg. These treated eggs were 
incubated in sanitized chambers and hatched after 
approximately 60 days. Hatchlings were placed in beakers of 
sterile water. Assays of their excretions were performed 
periodically to test for the presence of Salmonella spp 
(Siebeling et al., 1974).
The level of antibiotic that exists in the treated egg 
is unknown (Barnes et al., 1973). For this reason, studies 
were performed using to determine the concentration of 
gentamicin required for successful elimination of Salmonella 
spp (Siebeling et al., 1984). Over a three year period, one 
million turtle eggs from ten different farms were treated 
using solutions of 500 ng/ml or greater. After the first and 
second years, none of the turtles that hatched from treated 
eggs excreted Salmonella, while 45% from nontreated eggs 
excreted these pathogens. In the third year, 0.15% of the 
hatchlings from treated eggs excreted Salmonella. Prior to 
antibiotic treatment 49% of the hatchlings excreted these 
organisms. These studies revealed that the gentamicin dip 
solution must be maintained near a concentration of 1000 
Hg/ml for successful elimination of Salmonella spp (Siebeling 
et al., 1984). When lower concentrations of gentamicin were
4used, gentamicin resistant Salmonella were consistently 
observed.
In 1990, the Louisiana legislature passed a law 
requiring the analysis of samples by state approved 
veterinarians at federally-approved laboratories in Baton 
Rouge and Kenner. This law mandated that excretion assays be 
performed on a representative number of one year old turtle 
hatchlings from each turtle production lot. Detection of 
Salmonella within these samples would cause all hatchlings 
and viable eggs from that lot to fail inspection, thus 
prohibiting their exportation and sale. Since foreign 
customers, such as Japan, do not require testing and 
inspection of imported turtles or eggs, certain farmers 
outside of the Turtle Farmers and Shippers Association 
believe that procedures mandated by state law are unnecessary 
and unconstitutional.
The gentamicin sulfate used in egg treatment is a 
mixture of the four members of the family of gentamicins: 
gentamicin Clt gentamicin Cla, gentamicin C2, and gentamicin 
A (Benveniste and Davies, 1973b). Different Micromonospora 
species produce these gentamicin complexes (Matkovic et al., 
1984). For example, gentamicin C complex is produced by M. 
purpurea, while sisomycin, an aminoglycoside closely related 
to gentamicin, is produced by M. rosea. The gentamicin 
family is a subclass of deoxystreptamine aminoglycoside 
antibiotics composed of three polyamine hexose rings (Figure 
1). Ring I, pupurosamine, and ring II, 2-deoxystreptamine,
5R i
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Figure 1. Structure of the gentamicins. The basic structure 
shared by the members of the gentamicin family is shown. The 
three hexose rings are indicated as follows: ring I,
purpurosamine ,* ring II, 2-deoxystreptamine; and ring III, 
gentosamine. The presence of functional groups (e.g., OH or 
CH3) at positions R, through Rs determines the specific member 
of the gentamicin family.
are contained in all gentamicins. Ring III is gentosamine 
(in gentamicin A) or garosamine (in gentamicins Cla, C2, or 
C^). Rings I and III are attached to ring II at nonadjacent 
hydroxyl groups. Identification of a specific gentamicin 
aminoglycoside is based on the presence of specific 
functional groups (R groups) on the hexose rings. These 
structural distinctions may be important in terms of 
substrate specificities of antibiotic inactivating enzymes 
produced by actinomycetes and enteric organisms.
The effectiveness of gentamicin against a wide range of 
Gram-positive and Gram-negative bacteria gives the 
aminoglycoside clinical and industrial importance. The 
inhibitory effect includes binding to and complete inhibition 
of initiating ribosomes, partial inhibition of preformed 
polysomes, increased rigidity and misreading of ribosomes, 
and irreversible uptake of the antibiotic due to membrane 
damage (Bryan, 1982; Davies and Smith, 1968; Davis et al., 
1974; Davis, 1987; Hancock, 1981b). The generally accepted 
mechanism of gentamicin uptake and bacteriocidal action 
occurs in three stages: (1) energy-independent binding (EIB) , 
(2) energy-dependent phase I (EDPI) , and (3) energy-dependent 
phase II (EDPII), (Bryan and Van den Elzen, 1977; Foster, 
1983; Taber et al., 1987).
I. Enerav-independent binding.
This stage involves loose ionic binding between the 
polycationic aminoglycoside and the anionic cell surface.
The association occurs rapidly, is not affected by inhibitors 
of energized uptake, and is readily reversible. It can be 
markedly reduced by washing cells with solutions of various 
salts, particularly high concentrations of monovalent or low 
concentrations of divalent cations (Bryan and Van den Elzen, 
1977; Campbell et al., 1980). The ionic interaction between 
gentamicin and the cell surface differs among Gram-negative 
and Gram-positive cells (Taber et al., 1987). In 
Gram-negative cells, the antibiotic can passively diffuse 
through the outer membrane by hydrophilic means through outer 
membrane pores, such as OmpC and OmpF in E. coli or by 
hydrophobic means as it becomes solubilized in the 
phospholipid bilayer. Capsules and exopolysaccharides are 
poor barriers, decreasing the free diffusion of the 
antibiotic only slightly. In Gram-positive cells, gentamicin 
may bind negatively-charged teichoic acids exposed on the 
cell surface. The thick peptidoglycan layer, however, 
prevents immediate passage into the cell.
II. Enerav-dependent phase I.
The rate and duration of this phase depends on the 
external concentration of the aminoglycoside (Bryan and Van 
den Elzen, 1977). The slow initial passage of gentamicin 
across the cytoplasmic membrane requires proton motive force 
(Bryan and Kwan, 1983; Miller et al., 1980). Several 
studies indicate that active respiration is required for 
aminoglycoside uptake and lethality. Treatment of cells with
inhibitors of electron transport prevents cell killing by 
these antibiotics (Bryan et al., 1976; Campbell et al, 1980; 
Hancock, 1962). Similarly, cells treated with uncouplers of 
ATP synthesis from the electron transport system, which 
dissipate proton motive force across the cell membrane, do 
not take up aminoglycosides (Bryan et al., 1976; Hancock, 
1981a) . Furthermore, anaerobically growing E. coli that does 
not use electron transport to generate proton motive force 
cannot accumulate gentamicin (Taber et al., 1987).
The specific gentamicin carrier(s) has not been 
identified. It is possible that gentamicin transport occurs 
via a sugar or aminosugar transport system, since these 
compounds share structural similarities (Alper and Ames, 
1978) . It is not known whether specific proteins act as 
carriers or ionic interaction with electron transport chain 
components is required. Respiratory ubiquinone in E. coli 
(Bryan and Van den Elzen, 1977) and cytochrome d in 
Pseudomonas aeruginosa (Bryan and Kwan, 1981) appear to be 
involved in gentamicin accumulation.
In Salmonella typhimurium, catabolite repression also 
appears to participate in gentamicin resistance (Alper and 
Ames, 1978). Decreased cellular concentration of cAMP in 
times of glucose abundance cause the inhibition of 
transcription of certain genes. Many different metabolic 
processes are affected by catabolite repression. These 
include regulation of oxidative phosphorylation and proton 
motive force, and the synthesis of cell envelope proteins,
cytochromes and components of various transport systems. It 
is likely that the lack of one of these processes is the 
reason for increased gentamicin resistance.
Gentamicin at low concentrations within the cell binds 
chain-elongating ribosomes preferentially (Davis et al. ,
1974). This interferes with ribosomes and causes
mistranslation of proteins destined for the cell membrane 
(Davis et al., 1986). These mistranslated proteins damage 
the membrane structure and create new channels for 
aminoglycoside influx. As mistranslation and gentamicin 
uptake continue, there is increased ionic binding of the 
antibiotic to components within the cell. This autocatalytic 
mechanism ultimately leads to irreversible uptake of 
gentamicin. This signals the end of energy-dependent phase 
I.
Intracellular divalent cations, namely Mg2+ and Ca2+, 
may compete with aminoglycosides for binding sites within the 
cell, thus antagonizing the bacteriocidal mechanism. 
Inhibitors of protein synthesis, such as chloramphenicol, 
disrupt this stage of gentamicin uptake. This indicates that 
protein synthesis is required for effective cell killing 
(Bryan and Van den Elzen, 1976; Hancock, 1981b). Membrane 
damage due to incorporation of mistranslated proteins has 
been confirmed by electron microscopy studies (Gilleland et 
al., 1989).
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III. Enerav-dependent phase II.
The third and final stage of gentamicin uptake occurs 
when sufficient drug accumulates within the cell to bind all 
ribosomes, including initiating ribosomes. As was the case 
with the second stage, this stage is energy-dependent since 
antibiotic transport occurs against a concentration gradient. 
During this stage an enormous amount of gentamicin interacts 
with the cytoplasmic membrane. As the membrane becomes more 
permeable, Na+-K+ transport is impaired and respiration is 
partially uncoupled (Davis et al., 1986; Davis, 1987). In 
addition, the antibiotic binds to the S12 protein of the 3OS 
ribosomal subunit, possibly altering the shape of the 
ribosome (Ahmad et al., 1980). This probably prohibits
ribosome-protein complex formation and initiation of protein 
synthesis. Eventually protein translation ceases, signaling 
the onset of cell death.
The early stages of gentamicin uptake and bacteriocidal 
action may be circumvented by various resistance mechanisms 
(Davies and Smith, 1978; Hancock, 1981a and 1981b), which 
include spontaneous mutation and gene-encoded resistance. 
Each has been studied extensively in E. coli and other genera 
in the Enterobacteriaceae. These mutations, which occur at 
a rate of 1 in 10® cells, reduce the binding of 
aminoglycosides to ribosomes, impair transport into the cell, 
or affect outer membrane proteins. Aminoglycoside resistance 
obtained by spontaneous mutation is variable.
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IV. Ribosomal mutations.
In E . coli, the binding of a streptomycin molecule to 
a ribosome is 1:1 (Ahmad et al., 1980; Buckel et al., 1977; 
Thorbjarnardottir et al., 1978). Only one molecule of 
streptomycin is required to bind protein S12 and inhibit 
ribosomal function. Therefore, a single rpsL mutation per 
ribosome is sufficient for high-level streptomycin resistance 
(MIC >50 (iq/ml) . These mutations (DeWilde et al. , 1975)
result in an altered structure of protein S12 and prevent 
binding of the aminoglycoside to the ribosomal 3OS subunit. 
Since there are multiple ribosomal sites with different 
binding affinities for gentamicin, a single-step mutation can 
confer only a low level of resistance (MIC <25 i^g/ml) (Buckel 
et al., 1977) There appears to be one high affinity binding 
site and multiple low affinity sites. For example, the rplF 
mutant of E . coli which contains an altered ribosomal protein 
L6, exhibits only a low level resistance to gentamicin.
V. Membrane transport mutations.
Spontaneous mutations which disrupt membrane 
energization will confer gentamicin resistance. In E . coli, 
for example, unc mutants have defective membrane spanning 
Mg2+-Ca2+ATPases (Thorbjarnardottir et al., 1978). Such 
mutants are unable to maintain a normal proton gradient 
across the cell membrane. E. coli hemA mutants are 
cytochrome deficient and have no electron transport system 
(Bryan and Van den Elzen, 1977; Hancock, 1981a). Similarly
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ubiD mutants have reduced levels of ubiquinone. All of these 
mutations inhibit gentamicin accumulation and render the cell 
gentamicin resistant.
As with single a ribosomal mutation, a single unc 
mutation is not sufficient for high level resistance (Buckel 
et al, 1977). However, the effects of spontaneous mutations 
are additive and high level gentamicin resistance can be 
obtained in sensitive E. coli by a minimum of two mutational 
events (Ahmad et al., 1980). An rplF mutation will increase 
the level of gentamicin resistance 5-10 fold, while an unc 
mutation increases resistance 10-20 fold. Aminoglycosides, 
such as gentamicin, kanamycin, and neomycin, share similar 
structural features and, as a consequence, spontaneous 
mutations selected with one of these agents often confer 
resistance to the others (Buckel et al., 1977).
VI. Outer membrane mutations.
Low-level gentamicin resistance is often associated with 
mutations affecting outer membrane proteins of Gram-negative 
cells. For example, gentamicin resistant mutants of 
Pseudomonas aeruginosa PAOl were found to have higher than 
normal levels of the major outer membrane protein, HI 
(Gilleland et al., 1989; Nicas and Hancock, 1980). This 
protein functions as an outer membrane Mg2+ binding site, 
which gentamicin binds prior to passage through the membrane. 
Also, porin la deficient mutants of E. coli are defective in 
hydrophilic antibiotic uptake (Foulds and Chai, 1978). In
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both examples the transport of gentamicin may be blocked or 
inhibited, delaying the onset of EDPII.
High level gentamicin resistance often involves gene- 
encoded resistance proteins. Genes which confer gentamicin 
resistance can be carried by plasmids or transposons 
(Benveniste and Davies, 1973b; Bryan, 1982; Davies and Smith, 
1978; Rubens et al., 1979). These genes may remain 
independent of the host chromosome (as in a plasmid) or 
become incorporated by homologous recombination, site- 
specific recombination, or transposition. Most
clinically-significant resistance is due to the presence of 
resistance plasmids, also called R plasmids or R factors 
(Bryan, 1982; Davies and Smith, 1978). The size of R 
plasmids range from 1-400 kb depending on whether they are 
conjugative or nonconjugative. Although plasmids which carry 
resistance to neomycin-kanamycin and to streptomycin are the 
most common (Benveniste and Davies, 1973b), both conjugative 
and nonconjugative plasmids conferring gentamicin resistance 
have been detected in a wide variety of bacteria. Recent 
nosocomial outbreaks of gentamicin-resistant 
Enterobacteriaceae have been attributed to transfer of these 
R factors by conjugation (Vliegenthart et al., 1989).
Several composite transposons also carry gentamicin 
resistance genes: Tnl404, Tnl406, Tnl4ll, Tnl412, Tnl413,
Tnl699 and Tn2922 (Lafond et al., 1989; Martin et al., 1987; 
Wohlleben et al., 1989). Insertion sequences or partial 
insertion sequences common to several transposons are found
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upstream of many resistance genes (Allmansberger et al., 
1985; Martin et al., 1987). These genes have the potential 
to disseminate among a wide range of bacteria and can become 
incorporated into the bacterial genome. The resistance genes 
carried by R plasmids and transposons often encode ribosomal 
methylases, outer membrane proteins, or aminoglycoside 
modifying enzymes.
VII. Ribosomal methylases.
Modification of ribosomal subunits by methylases does 
not occur in Enterobacteriaceae. However antibiotic-producing 
bacteria, such as actinomycetes, use ribosomal modification 
as a means of defense against their own products (Cundliffe, 
1989). This mechanism, which can be detected using 
reconstitution assays for in vitro translation (Thompson et 
al., 1985; Zalacain and Cundliffe, 1989), confers 
aminoglycoside resistance via post- transcriptional 
methylation of the rRNA by inducible or constitutively 
expressed methylases. Some ribosomal methylases act on free 
rRNA but not mature ribosomes (Cundliffe, 1989). Such 
resistance genes in actinomycetes must be expressed 
constitutively if the organism is to use this mechanism for 
self-defense. Most cases of aminoglycoside resistance by 
target site modification involve the 16S rRNA in the 3OS 
subunit. It is likely that methylation prevents binding of 
the antibiotic to the ribosome. Kanamycin and gentamicin 
resistance in Streptomyces occurs when the 16S RNA of the
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small (30s) subunit is methylated by the product of the kgmB 
gene (Skeggs et al., 1987). Methylation, which occurs at two 
specific adenine residues, confers high level 
resistance.
When Streptomyces tenebrarius DNA carrying gentamicin 
resistance genes was cloned into Streptomyces lividans 
(Thompson and Cundliffe, 1985; Keleman et al., 1991) a 
methylation pattern similar to that of kgmB methylases was 
observed. The ribosomal 3OS subunit of S. lividans was made 
resistant by a single gene product methylating at a single 
specific site on the Streptomyces 16S rRNA. In this case, 
kanamycin-gentamicin resistance genes (encoded by kgmA gene) 
methylated the G-1405 residue, converting it to 7- 
methylguanosine (Beauclerk and Cundliffe, 1987; Cundliffe, 
1989).
Several gentamicin-producing stains of Micromonospora 
devoid of antibiotic inactivating enzymes were found to use 
only ribosomal modification for gentamicin resistance 
(Matkovic, 1984). Recently a second type of ribosomal 
methylase was found. These rRNA methyltransferases encoded 
by grm genes in Micromonospora purpurea and M. rosea (Keleman 
et al., 1991) are highly conserved in Micromonospora spp. 
This mechanism of gentamicin resistance, currently under 
study, appears to be different from that of the kgm 
methylases.
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VIII. Outer membrane proteins.
Non-enzymatic gentamicin resistance has been detected in 
a number of Pseudomonas aeruginosa strains (Kono et al., 
1977). These strains do not produce antibiotic inactivating 
enzymes or ribosomal methylases. Plasmid encoded outer 
membrane proteins appear to be involved in decreased 
permeability to gentamicin, streptomycin, and kanamycin. 
These proteins may block the channels used for gentamicin 
uptake or interfere structurally with the cell envelope, 
where the ability of the aminoglycosides to bind the outer 
membrane may also be decreased.
IX. Aminoglycoside modifying enzymes.
The most common form of aminoglycoside resistance is due 
to constitutively expressed modifying enzymes (Benveniste and 
Davies, 1973b; Hancock, 1981a and 1981b). These enzymes 
inactivate the antibiotic by addition of a specific 
functional group to an amino or hydroxyl residue on the 
antibiotic, decreasing the drug's affinity for the ribosome. 
Such enzymatic modification results in failure of the 
aminoglycoside to induce EDPII, since the antibiotic no 
longer binds the target (Bryan, 1982). These enzymes are 
classified according to their mechanism of modification 
(N-acetylation, O-nucleotidylation, or O-phosphorylation) and 
the site of modification on the aminoglycoside (Benveniste 
and Davies, 1973b; Haas and Dowding, 1975). Phenotypical 
resistance profiles of bacterial isolates (Allmansberger et
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al., 1985; Barg, 1988; van de Klundert et al., 1984) by
minimum inhibitory concentration (MIC) assays have been 
determined. However, MICs are an unreliable measurement of 
enzyme production and specific isotype characterization 
because it does not discriminate among the modifying enzymes. 
Furthermore resistant isolates may produce more than one 
modifying enzyme.
More reliable methods used to detect aminoglycoside 
modifying enzymes include colorimetric assays (Benveniste and 
Davies, 1971) and phosphocellulose binding assays (Bongaerts 
and Vliegenthart, 1988; Vliegenthart et al., 1989). For
example, a colorimetric assay which employs 5', 5'-dithiobis- 
(2-nitrobenzoic acid) (DTNB) can be used to test acetylation 
activity. The DTNB solution detects sulfhydryl bonds formed 
when an acetate is transferred from acetylCoenzyme A to an 
amino group on the antibiotic. The phosphocellulose paper 
binding assay detects enzymatic transfer of radiolabeled 
functional groups from the substrate to the antibiotic.
Aminoglycoside nucleotidyltransferases (ANT) utilize 
nucleotides to modify the hydroxyl groups on the 
aminoglycoside antibiotics (see structure, page 5). These 
enzymes are found among many Gram-positive and Gram-negative 
bacteria. Only the ANT(2 11) nucleotidyltransferase modifying 
the 2" position of aminohexose III, however, confers high- 
level gentamicin resistance to Enterobacteriaceae and 
Pseudomonas aeruginosa strains (Davies and Smith, 1978; 
Shannon and Phillips, 1982). Nucleotidyltransferases can
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utilize either ribo- or deoxyribonucleotide triphosphates as 
donors of functional groups in the enzymatic mechanism but 
appear to prefer ATP. For this reason these enzymes are 
often called adenyltransferases.
Aminoglycoside phosphotransferases (APH) are widely 
distributed among Gram-positive and Gram-negative bacteria. 
However, the only phosphotransferase which imparts gentamicin 
resistance is 2"-O-phosphotransferase, APH(2") (Shannon and 
Phillips, 1982). This enzyme, which phosphorylates the 2" 
hydroxyl group of aminohexose III, has been found in several 
Staphylococcus spp and Streptococcus faecalis.
Aminoglycoside acetyltransferases (AAC) are the most 
prevalent mechanism of gentamicin resistance among the 
Enterobacteriaceae (Kettner et al., 1987; Vliegenthart et 
al., 1989). These enzymes catalyze the transfer of acetate 
from acetyl Coenzyme A to an amino group on the antibiotic. 
Acetylation of gentamicin, however, is not always associated 
with gentamicin resistance since not all amino groups play a 
role in ribosomal binding. The aminoglycoside-N-acetyltrans- 
ferases can be placed into three groups: AAC(6'), AAC(2'), 
and AAC(3) (Davies and Smith, 1978). Enzymes can be further 
classified as isoenzymes based on the range of substrates 
enzymatically modified. The AAC(6') group is composed of 
four isoenzymes encoded by aacA genes (Tenover et al., 1988) . 
These enzymes acetylate the 61 position on gentamicin but are 
not often associated with high-level gentamicin resistance in 
organisms other than Pseudomonas aeruginosa. A second group
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of enzymes, AAC(2'), is produced from aacB genes carried by 
Providencia spp (Foster, 1983). These mediate high level 
resistance by acetylating the 2' position. Initial studies 
referred to these enzymes as gentamicin acetyltransferase II 
(Chevereau et al., 1976).
The AAC(3) enzymes acetylate position 3 on gentamicin 
and are encoded by aacC genes (Vliegenthart et al., 1989). 
The isoenzymes of this group confer high level resistance 
against other aminoglycosides and can be identified based on 
in vitro substrate profiles. There appear to be eight 
isoenzymes of this group (I, la, II, III, IV, V, VI, VII) 
although few have been fully characterized. Isoenzyme VII 
has been detected in antibiotic-producing strains, while the 
remaining enzymes are produced by enteric organisms and 
pseudomonads. In Gram-negative bacteria, only the genes 
encoding isoenzymes I through IV from Gram-negative bacteria 
have been sequenced (Brau and Peipersberg, 1984; Tenover et 
al., 1989; Vliegenthart et al., 1991; Vliegenthart et al., 
1989). Acetyltransferases I and la share homology and 
enzymes la and III are confined to pseudomonads. Isoenzyme 
VII, cloned and sequenced from Streptomyces rimosus forma 
paromomycinus, shows primary structural homology with a 
plasmid-encoded AAC(3)-II from Klebsiella (Lopez-Cabrera et 
al., 1989). The sequences of the genes encoding isotypes II 
and III are nearly identical suggesting protein structure 
homology between II and III as well. Substrate profiles for 
isotypes II and V are identical and further study is required
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before they can be typed as different acetyltransferases 
(Barg, 1988; Vliegenthart et al., 1989). Enzyme AAC(3)-VI 
has recently been found in nine strains of Enterobacteriaceae 
(Vliegenthart et al., 1991).
Aminoglycoside modifying enzymes are found in low 
concentrations in the cell (Davies and Smith, 1978). 
However, the high affinities of these enzymes for their 
substrates, coupled with inefficient transport of 
aminoglycosides across the cell membrane, appears sufficient 
for high level resistance. It has been suggested that 
certain aminoglycoside modifying enzymes may be located 
within the bacterial periplasmic space, while others remain 
in the cytoplasm (Davies and Smith, 1978). It is highly 
unlikely that aminoglycoside modifying enzymes reside in the 
periplasmic space since they require cofactors such as ATP 
and acetyl Coenzyme A. A loose ionic association of these 
enzymes with the cell membrane seems logical since they must 
modify the antibiotic before it reaches the ribosome. 
Recently, these enzymes were found to be localized in the 
cytoplasm of Escherichia coli (Vliegenthart et al., 1991).
Little is known concerning the origins of amino­
glycoside modifying enzymes. Several facts suggest that 
enzymatic inactivation of aminoglycosides evolved in 
actinomycetes. While aminoglycoside acetylation is most 
prevalent in Enterobacteriaceae, it occurs in actinomycetes 
as well (Benveniste and Davies, 1973a; Cundliffe, 1989; 
Thompson and Gray, 1983). The role of aminoglycoside
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modifying enzymes, such as AAC(3)-VII, in antibiotic- 
producing strains appears to be identical to that in enteric 
bacteria since these enzymes catalyze identical reactions.
Comparison of the primary structure of aminoglycoside 
acetyltransferases from organisms in the Enterobacteriaceae 
reveals several conserved regions similar to enzymes found in 
actinomycetes. For example, the primary structure of 
gentamicin AAC(3)-VII and that for a presumed AAC(3)-III 
share strong homology (Lopez-Cabrera et al., 1989; 
Allmansberger et al., 1985). The conserved regions may 
represent specific binding motifs significant to enzyme 
function such as similar substrate and cofactor binding 
sites. Furthermore, similar substrate specificities exist 
for modifying enzymes among producing and nonproducing 
strains (Lopez-Cabrera et al., 1989; Vliegenthart et al., 
1989) . For these reasons, it has been suggested that these 
enzymes originated as a means of self-defense in antibiotic- 
producing strains, such as Streptomyces, or organisms living 
symbiotically with them (Cundliffe, 1989).
In addition to similarities among modifying enzymes, 
characteristics of the genes encoding them suggest a possible 
relationship between modifying enzymes derived from 
actinomycetes and Enterobacteriaceae (Gray and Fitch, 1983). 
The high G+C content of transferase genes carried by 
bacterial plasmids and chromosomes reflects that of 
actinomycete genomic DNA (Allmansberger et al., 1985; Enquist 
and Bradley, 1971; Lopez-Cabrera et al., 1989; Vliegenthart
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et al., 1989). Because the g+C content of most
Enterobacteriaceae chromosomes is approximately 50% or less 
(Genes IV, Chapter 10) it appears that acetyltransferase 
genes did not originate in these organisms.
Codon usage is nonrandom for homologous genes contained 
in taxonomically nonrelated bacteria (Bennetzen and Hall, 
1982). Analysis of codon usage based on the organisms' tRNA 
pools suggests that resistance genes originated in 
actinomycetes. The preferred codons in Streptomyces have a 
high proportion of G or C at the 3' position (Bibb et al.,
1984). For many antibiotic biosynthetic and antibiotic 
resistance genes in Streptomyces these codons are used 
exclusively. For example, only codons GUC and GCC are used 
for valine and alanine, respectively, in the 
phosphotransferase gene (Thompson and Gray, 1983). For the 
majority of aminoglycoside resistance genes, either carried 
by R plasmids or incorporated into the genome of E. coli, 
codons with a high G+C content are found. This suggests that 
aminoglycoside resistance genes did not evolve in E. coli and 
related enteric organisms.
The efficient translation of G+C rich genes relies on 
tRNA species carrying G+C rich anticodons (Grosjean and 
Fiers, 1982; de Boer and Kastelein, 1986). These tRNAs are 
abundant in Streptomyces (Bibb et al. , 1984) and may allow 
high level expression of genes encoding modifying enzymes. 
Such tRNAs are synthesized in low amounts in E. coli. This 
may result in inefficient translation and low level
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expression of this gene in e . coli. Organisms such as 
Citrobacter spp, Proteus spp and Salmonella spp have codon 
preferences similar to E. coli (de Boer and Kastelein, 1986). 
This implies constraints on the expression of G+C rich genes 
in these organisms as well.
The translational efficiency of mRNA transcribed from 
antibiotic resistance genes in E. coli can be compared with 
that of similar genes in Streptomyces or other organisms by 
calculating a codon bias index (Bennetzen and Hall, 1982) for 
the gene within each organism. This index provides a means 
of determining preferred codon usage above random chance and 
accounts for differences in the number of possible codons for 
each amino acid. The very low translational efficiencies for 
G+C rich genes in E. coli (de Boer and Kastelein, 1986) 
compared to the very high value that could be calculated for 
Streptomyces (Thompson and Gray, 1983) supports the idea that 
G+C rich genes may have originated in antibiotic-producing 
organisms (Grosjean and Fiers, 1982).
It is possible that resistance genes may have been 
transferred from actinomycete genomic DNA by transposons to 
form R-plasmids. The presence of transposons carrying 
gentamicin resistance genes and insertion sequences upstream 
of certain acetyltransferase genes support this idea. In 
addition, plasmids and transposons are readily passed among 
enteric organisms through conjugation (Rubens et al., 1979). 
The exact mechanism as to how these genes passed from 
actinomycetes to enterics is unknown since Gram-positive
organisms are incapable of conjugating with Gram-negative 
bacteria. It is possible that R-plasmids or transposons 
carrying gentamicin resistance were initially transferred 
from actinomycetes to enterics via bacteriophage. However, 
a bacteriophage that infects both Gram-negative and Gram- 
positive bacteria has not yet been found.
The following studies, which briefly address this issue, 
were designed mainly to identify mechanisms of aminoglycoside 
resistance observed in enteric bacteria isolated from 
turtles. These experiments describe the isolation and 
characterization of a gentamicin resistance gene and use of 
this gene as a probe to detect homologous DNA fragments in 
other isolates. The size and activity of the protein 
encoded by the gene were also analyzed.
EXPERIMENTAL APPROACH
Enteric isolates were obtained from numerous sources on 
commercial turtle farms. These organisms were identified and 
characterized according to the level of gentamicin resistance 
as measured by minimum inhibitory concentration assays. 
Several of these isolates were resistant to gentamicin. 
Levels of resistance to antibiotics other than gentamicin 
were also determined. Initial characterization of the 
observed gentamicin resistance included the screening of 
gentamicin-sensitive and gentamicin-resistant isolates for 
the presence of resistance plasmids.
Chromosomal DNA from three genera of gentamicin- 
resistant organisms was used for the isolation of a 
gentamicin resistance gene. A physical map of the gene, the 
location of the gene on the fragment of chromosomal DNA 
conferring gentamicin resistance, and the direction of 
transcription were determined by restriction endonuclease 
mapping and deletion analysis. The effect of gene dosage on 
expression of this resistance gene was analyzed using vectors 
of varying copy number. In addition, the effect of promoter 
strength was studied by cloning the resistance gene into a 
plasmid containing a strong promoter.
The size of the encoded protein was determined using 
protein labeling and polyacrylamide gel electrophoresis, 
Protein activity was tentatively identified using
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colorimetric assays. Following nucleotide sequencing, the 
predicted amino acid sequence was determined and the 
identification of the gene and encoded protein were 
confirmed. Finally, the gentamicin resistance gene was used 
as a probe in DNA hybridization studies to detect homologous 
genes in other enteric organisms isolated from turtles.
materials and methods
I. Chemicals.
Gentamicin, kanamycin, neomycin, streptomycin, 
ampicillin, 5,51-dithiobis-(2-nitrobenzoic acid) (DTNB), 
phenylmethylsulfonylfluoride, 5-bromo-4- chloro-3-indolyl- 
p-D-galactoside (Xgal), and isopropyl-p-D-thio-galactoside 
(IPTG) (Sigma Chemical Company, St. Louis, MO) were used. 
Protein assay reagents were purchased from BioRad 
Laboratories (Richmond, CA). Sequencing kits were purchased 
from United States Biochemical (Cleveland, OH). Restriction 
enzymes and DNA modifying enzymes (Bethesda Research 
Laboratories, Gaithersburg, MD and New England Biolabs, Inc., 
Beverly, MA) were used according to the reaction conditions 
recommended by the supplier. 35S-methionine, [a32P]-dATP, 
and [a35S]-dATP were obtained from NEN Research Products, 
Dupont, Wilmington, DE.
II. Bacterial strains and media.
Methods for sample collection, bacterial isolation, and 
bacterial identification have been described previously 
(Izadzoo et al., 1987; Siebeling et al., 1984; Siebeling et 
al., 1975). Citrobacter freundii, Proteus vulgaris, and 
Salmonella enteritidis (courtesy of Dr. R.J. Siebeling) were 
grown in Luria (L) broth (Miller, 1972) and MacConkey agar 
(Difco Laboratories, Detroit, MI) at 37°C. When required for
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bacterial selection, 20 iig/ml gentamicin sulfate was added. 
Escherichia coli K-12 DH5aMCR (Bethesda Research Laboratories 
Gaithersburg, MD) , E. coli K-12 JM83 (Yanisch-Perron et al.,
1985) , E. coli K-12 ER1648 (New England Biolabs, Inc,
Beverly, MA) , E . coli JM103 (Hanahan, 1983) , and E. coli 
CSR603 (Coli Genetic Stock Center, New Haven, CT) were grown 
on Luria agar (Miller, 1972) at 37°C. E . coli cells 
containing recombinant plasmids were grown in the presence of 
35 /xg/ml ampicillin and 20 ^g/ml gentamicin.
III. Minimum inhibitory concentration (MIC) assays.
The level of antibiotic resistance for all bacterial 
isolates and strains carrying recombinant plasmids and 
plasmid constructs was measured by minimum inhibitory 
concentration assays (Thrupp, 1980) in L broth. Test 
organisms were grown overnight in 2 mis L broth. One ml of 
L broth was placed into 8 of 9 tubes. Then one ml of 200 
/xg/ml gentamicin stock solution was added to an empty tube, 
tube 1, and into tube 2 containing one ml of L broth. Tube 
2 was mixed and one ml was transferred to tube 3. These 
serial two-fold dilutions were continued through tube 8. In 
a fresh tube, the test organisms were diluted to a 
concentration of 105 cells/ml. One ml of the test culture 
was added to each serial dilution tube. After incubation at 
37°C for 18 hours without shaking tubes were examined 
macroscopically for growth. The lowest concentration of the 
drug showing no growth was read as the MIC.
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IV. Selection for spontaneous mutants resistant, to
gentamicin.
Gentamicin-sensitive (MIC value of 0.3 /Ltg/ml) and 
intrinsically-resistant (MIC of 100 /xg/ml) Citrobacter 
freundii and Proteus vulgaris were used to select spontaneous 
mutants. Each isolate was transferred step-wise to L agar 
containing gentamicin. Initially, each sensitive strain was 
plated on Luria agar without antibiotic. After 12 hours of 
incubation, single colonies were picked and transferred to 
medium containing 10 tig/m 1 gentamicin. Colonies, which grew 
in the presence of 10 /xg/ml, were transferred to plates which 
contained 50 or 100 /xg/ml gentamicin. Subsequent transfers 
were made to media which contained 300, 500, and 700 /xg/ml 
gentamicin.
A second class of spontaneous mutants was also selected 
from intrinsically-resistant (i.e., scored as resistant to 
gentamicin at the time of isolation) strains initially plated 
on Luria agar with 100 /xg gentamicin/ml. Single colonies 
were transferred to medium which contained either 500 /xg/ml, 
700 /xg/ml, 1 mg/ml, 10 mg/ml, or 50 mg/ml. Each spontaneous 
mutant from each class was passed six times on Luria agar 
without gentamicin to insure the presence of inheritable 
changes in gentamicin resistance. Final MIC values were then 
determined. Minimum inhibitory concentrations for
gentamicin, kanamycin, neomycin and streptomycin were also 
determined for each strain.
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V. Molecular cloning and subclonina.
Chromosomal DNA was isolated from C. freundii EA-2 and 
EA-3, P. vulgaris NS-4 and EA-6 and S. enteritidis SE-2 and 
SE-3 following treatment with 2% sarcosyl in HTE buffer, 
phenol extraction, and ethanol precipitation (Zyskind and 
Bernstein, 1989). C. freundii and P. vulgaris chromosomal 
DNAs were prepared for molecular cloning by partial digestion 
with Sau3AI (Silhavy et al., 1984). S. enteritidis SE-2 and 
SE-3 DNAs were prepared by complete digestion with Hindlll or 
EcoRI, respectively. T4 DNA ligase was used to ligate 
Sau3Al-digested chromosomal DNA to BamHI-digested plasmid 
pUC8 (Maniatis et al., 1982), while S. enteritidis DNA was 
ligated to plasmid pBR322 digested with either Hindlll or 
EcoRI. Escherichia coli DH5aMCR or ER1648 made competent by 
the method of Lederberg and Cohen (1974) were transformed 
with recombinant plasmids. Transformants resistant to both 
ampicillin (i.e., vector-encoded) and gentamicin were 
selected for analysis.
Recombinant plasmids were isolated from each gentamicin- 
resistant clone by the method of Birnboim and Doly (1979) . 
Plasmid DNAs were analyzed by restriction enzyme digestion 
followed by electrophoresis on 0.7% agarose gels in 
Tris-Borate-EDTA (TBE) buffer (Maniatis et al., 1982). 
Small, low molecular weight DNA fragments, obtained by 
restriction enzyme digestion, were resolved on 6% (30:0.5
monomer to bis ratio) polyacrylamide gels in TBE buffer. 
Subclones were generated following digestion and
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electroelution of the inserted DNA and ligation with vector 
pUC19 DNA (Maniatis et al., 1982) digested with the 
compatible enzyme(s).
VI. Plasmid isolation and mapping.
Cells were grown in 5 ml L broth or minimal media 
(Maniatis et al., 1982) overnight at 37°C and pelleted by 
centrifugation. To screen for the presence of endogenous 
plasmids in Citrobacter, Proteus, and Salmonella strains, 
four methods were used to enhance the detection of large 
plasmids. The methods used were the following: the alkaline
lysis procedure of Birnboim and Doly (1970), the SDS-gentle 
lysis technique of Kado and Liu (1981) , a lysozyme and Triton 
X-100 lysis procedure (Maniatis et al., 1982), and the SDS- 
lysozyme method of Gonzalez and Carlton (1980). Presence or 
absence of plasmids was determined following agarose gel 
electrophoresis. The large F' plasmid from E. coli JM103 
(Hanahan, 1983) was used as a control. Recombinant plasmids 
were digested with restriction endonucleases used singly or 
in pairs. Physical maps of recombinant plasmids were based on 
the size of restriction endonuclease-generated DNA fragments. 
Electrophoresis using agarose or polyacrylamide was used to 
determine fragment length; phage lambda DNA digested with 
iJindlll and pBR322 digested with Mspl were used as standards.
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VII. Blotting and hybridization analysis.
Chromosomal DNA was isolated from gentamicin-sensitive 
and gentamicin- resistant strains of C. freundii, P. 
vulgaris, and S. enteritidis (Zyskind and Bernstein, 1989). 
Recombinant plasmids were isolated from E. coli transformants 
(Birnboim and Doly, 1979). Approximately 4 ng of each 
chromosomal DNA sample digested with Hindlll and SalI were 
electrophoresed on 0.7% agarose gels. After sequential 
washes in 0.2M HC1 depurination solution, 0.5M NaOH-1.5M NaCl 
denaturation solution, and 1 M Tris-HCl-1.5M NaCl 
neutralization solution, the DNA was blotted from the agarose 
gel to a nylon membrane by Southern transfer (Maniatis et 
al., 1982). DNA hybridization was performed using a 
radiolabeled probe containing the C. freundii gentamicin 
resistance gene prepared by incorporation of [a32P]-dATP by 
nick translation (Maniatis et al., 1982). The probe was 
purified using a P-3 0 Biogel column (BioRad Laboratories, 
Richmond, CA) . Following hydration of the P-30 biogel resin 
in 10 mM Tris-100 mM NaCl-1 mM EDTA (TNE) buffer, fine 
unsedimented resin particles were poured off. A sterile 
Pasteur pipet was plugged with sterile siliconized glass 
wool. The resin suspension was poured into the plugged pipet 
and allowed to settle until the column was packed with resin. 
The level of TNE buffer was maintained above the level of the 
resin.
The nick translation reaction was stopped by addition of 
5% SDS—50mM EDTA-0.25% BPB. After addition of 2% dextran
blue, the reaction mixture was added to the column. The 
radiolabeled probe eluted with the dextran blue band. 
Prehybridization (Maniatis et al., 1982) to block nonspecific 
DNA binding was carried out for 2 hours at 42°C. For 
hybridization, 106 cpm of the probe was used. After 24 hours 
the membrane was washed sequentially at room temperature in 
sodium chloride-sodium citrate (SSC) and sodium dodecyl 
sulfate (SDS) solutions of gradually increasing stringency 
(Miller, 1972). The final wash in 0.1X SSC and 1.0% SDS was 
carried out at 42°C. Labeled DNA hybrids were detected by 
autoradiography.
VIII. Deletion analysis.
Using the information from the physical maps for the 
recombinant plasmids, portions of the insert fragments were 
deleted. Following restriction digestion and agarose gel 
electrophoresis, the recombinant plasmids minus the deleted 
DNA were purified by electroelution and recircularized using 
T4 DNA ligase (Maniatis et al., 1982). E. coli DH5aMCR cells 
made competent by the method of Lederberg and Cohen (1974) 
were transformed with the DNA. Ampicillin-resistant clones 
were picked to L agar containing ampicillin and gentamicin to 
score for gentamicin resistance. Specific deletions were 
confirmed by restriction endonuclease digestion and agarose 
gel electrophoresis using ifindlll-digested phage lambda DNA 
size marker. The loss of gentamicin resistance correlated 
with the deletion of specific DNA fragments.
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IX. Identification of plasmid-encoded proteins by maxicell
labeling technique.
Escherichia coli CSR603 was transformed with various 
subclones or pUC19. Presence of plasmids in transformants 
was confirmed by the method of Birnboim and Doly (1979) . 
Plasmid-encoded proteins were labeled with 3sS-methionine 
using a modification of the method of Sancar (Sancar et al. , 
1981) . Transformants were grown in 2 ml L broth with 50 
/xg/ml gentamicin or L broth containing 35 /xg/ml ampicillin 
prior to inoculation into K medium containing uridine. Cells 
were diluted into fresh medium and grown to 0.2 at OD600. 
After ultraviolet irradiation for 3 0 seconds at 450 
ergs/cm2/sec with stirring, cells were transferred to fresh 
K medium and incubated for 2 hours in the dark at 37°C. 
Cycloserine was added to a final concentration of 200 mg/ml 
and incubation was continued overnight.
After addition of fresh cycloserine and incubation for 
1 hour, 100 /x 1 of the culture was plated to test for 
surviving cells. Cultures were harvested by centrifugation, 
washed twice with sulfate-free Hershey medium, resuspended in 
fresh Hershey medium and incubated 1 hour at 37°C. Five 
/xCi/ml of 35S-methionine was added and incubation was 
continued for 1 hour. Cells were harvested, resuspended in 50 
/xl of a cell lysis buffer (Sancar et al., 1981) and boiled 
for 5 minutes. Cell-free protein extracts were analyzedby 
SDS-polyacrylamide gel electrophoresis using 500,000 cpm per 
lane on a 15% polyacrylamide gel in Tris-Borate-EDTA (TBE)
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buffer (Laemmli, 1970). The apparent molecular mass of 
proteins was determined relative to 14C-labeled protein 
standard mixture (Bethesda Research Laboratories, 
Gaithersburg, MD). Protein bands were visualized by 
autoradiography of dried polyacrylamide gels.
X. Determination of gentamicin acetvltransferase
specific activity.
Specific activity of gentamicin acetyltransferase was 
measured as a function of growth for C. freundii EA-2 and for 
E. coli carrying pMAB222. Cells were grown in L broth 
containing 5 ng gentamicin/ml. Optical density (Kletts) was 
measured at 15 or 30 minute intervals, and 5 ml of culture 
were taken for extract preparation. Growth curves and 
acetylation activities are shown in Figure 7, Panels A and B.
Gentamicin acetyltransferase activity was also 
deterimined for other strains. Intrinsically-resistant 
isolates were grown in L broth containing 5 y.g gentamicin/ml 
to 100, 160, and 280 Klett units. E . coli DH5aMCR and E. coli 
transformants were grown to 80, 160, and 240 Klett units. 
Five ml of cells were harvested by centrifugation and washed 
twice with 10 mM Tris-50 mM NH4C1 (pH 7.5) at 4°C. The 
pellet was resuspended in TMAK buffer: 20 mM Tris, 10 mM
MgC2H302, 25 mM NH4C1 and 10 mM KCl (pH 7.5).
Phenylmethylsulfony1-fluoride (1 mg/ml in ethanol) was added 
to a final concentration of 7% (w/v) for protease inhibition.
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While on ice, cells were disrupted by sonication (Heat 
Systems-Ultrasonic inc., Farmingdale NY) at a power setting 
of 2 using 3-4 10 second pulses. Cell debris was removed by 
centrifugation. The cell-free extract was removed and stored 
at -70°C or used immediately for acetyltransferase assays.
Aminoglycoside acetyltransferase activity was assayed in 
TMAK buffer using a modification of the method of Shaw 
(1975). A solution containing DTNB, cell extract, and acetyl 
Coenzyme A were used to measure the background level of DTNB 
reduction (i.e., acetyl Coenzyme A deacetylation and 
subsequent formation of Coenzyme A-SH) at 25°C. A reference 
cuvette containing this solution was used for background 
contrast throughout the colorimetric assay. To determine 
aminoglycoside acetylation by cell extracts, gentamicin, 
kanamycin or neomycin was added to the sample cuvette 
containing this mixture. The yellow color produced upon DTNB 
reduction was measured and recorded spectrophotometrically. 
The initial reaction rate determined for the sample curve was 
used to calculate aminoglycoside acetyltransferase activity 
(Appendix A) . Protein concentration in cell free extracts 
was determined as described by Bradford (1976) using the 
BioRad protein assay (BioRad Laboratories, Richmond CA) . 
Acetyltransferase specific activity was calculated for each 
sample as shown in Appendix A.
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XI. Cloning of a gentamicin resistance gene into PUC18. PUC19
and PMAK7 05.
A 900 bp fragment containing the gentamicin resistance 
gene was purified from recombinant clones by digestion with 
EcoRV and Sal I, agarose gel electrophoresis, and
electroelution (Maniatis et al., 1982). This fragment was 
ligated (Maniatis et al., 1982) into Smal-Sall digested pUC18 
and pUC19 to generate the plasmids pMAB901 and pMAB902, 
respectively. E. coli DHSaMCR cells made competent by the 
method of Lederberg and Cohen (1974) were transformed and 
recombinant plasmids were isolated from gentamicin resistant 
transformants by the method of Birnboim and Doly (1979). 
Presence and size of insert were confirmed by agarose gel 
electrophoresis.
To integrate the gentamicin resistance gene into the 
chromosome of E . coli DHSaMCR, a 2.3 bp Hindlll-Sall insert 
was ligated into plasmid pMAK705, which is temperature 
sensitive for replication (Hamilton et al., 1989). Cells 
containing the resulting plasmid, pMAB2 300, were plated on 
MacConkey agar containing 40 fig gentamicin/ml and incubated 
at 30°C, the permissive temperature. Transformants were 
picked to MacConkey agar containing gentamicin and incubated 
at 42°C, the nonpermissive temperature. Gentamicin resistant 
transformants growing both at 30°C and 42°C were tested for 
plasmids by Birnboim and Doly (1979) and MIC assays. 
Plasmidless gentamicin-resistant transformants growing at 
42°C (i.e., cells in which the plasmid was integrated into
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the chromosome) were analyzed for gentamicin 
acetyltransferase activity.
XII. Nucleotide sequencing.
Restriction fragments derived from recombinant plasmids 
were cloned into bacteriophage vector M13mpl9 (Yanisch-Perron 
et al., 1985) and transfected into E. coli JM103. Transfected 
cells were added to 0.8% H20 top agar containing 0.1M IPTG, 
2% solution of Xgal in dimethylfluoride, and E. coli JM103 
helper cells. After incubation overnight at 37°C, white 
plaques (i.e., areas of slow growing transfected cells) were 
picked into L broth containing 1:50 dilution of E. coli JM103 
and grown for 7 hours. After centrifugation, supernatants 
containing phage lysates were stored at -20°C. Replicative 
forms of the phage were isolated from pelleted cells by 
Birnboim and Doly (1979) . Presence and size of inserts to be 
sequenced were confirmed following restriction endonuclease 
digestion and polyacrylamide gel electrophoresis. Lysates 
from clones of interest were used to prepare single-stranded 
templates. Templates carrying inserts in opposite
orientation were analyzed and confirmed by the C-test 
(Hackett et al., 1984). Templates were checked on agarose 
gels prior to chain termination sequencing reactions using 
the protocol supplied with the Sequenase Version 2.0 
sequencing kit (United States Biochemical, Cleveland, OH) . 
The universal M13 primer was used. The [a35S]-dATP labeled 
fragments were separated on 6% polyacrylamide gels containing
8M urea. Gels were soaked in 5% acetic acid-15% methanol to 
remove urea, dried and exposed to Xray film overnight at room 
temperature.
RESULTS
40
I. A survey of gentamicin resistance in enteric
bacteria isolated from turtle farms.
Some of the genera of Gram-negative bacilli recovered 
from commercial turtle farms and their source are listed in 
Table 1. Citrobacter freundii and Proteus vulgaris were 
routinely recovered from nontreated and treated samples. The 
number of isolates which exhibited a given MIC for gentamicin 
resistance are listed in Table 1. Isolates with gentamicin 
MIC values of 6.2 fj.g/ml or less were scored as sensitive, 
while resistant organisms had MIC values of 12.5 ng/ml or 
greater. Of the 48 bacterial isolates recovered from 
non-treated sources, only three Proteus strains (i.e., pond 
water and nest soil) and three Salmonella strains (i.e., 
cloacal-swab adult female and nest soil) were resistant. 
Since turtle hatchlings produced by treated eggs were not 
released into the egg-laying population, the isolation of 
resistant enterics from adult females and the pond suggests 
that gentamicin resistance exists in the adult turtle 
population.
Twenty-four bacterial strains were isolated from eggs 
immediately after treatment with gentamicin (i.e., egg shell 
and egg homogenate) . Of these, five Pseudomonas spp were 
resistant, while the remaining 19 isolates were sensitive. 
Recent studies show that Pseudomonas spp resistant to
40
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TABLE 1*
Minimal inhibitory concentration of gentamicin for Gram-negative 
bacilli recovered from environment, egg, and turtles 
on a commercial turtle farm
MIC (pg/ml)b
Source Isolate Total6 <6.2 12.5 25 50 100
NON­
TREATED
pond water C. freundii 1 1
(PW) P. vulgaris 5 3 - - 2 -
S. enteritidis 7 7 - - - -
5. arlzonae 7 6 — — - —
cloacal- C. freundii 4 4 _ _ _ _
swab S. enteritidis 3 2 1 - - -
(CS)J S. arlzonae 5 5 “ — - —
nest soil C. freundii 3 3 _ _
(NS) P. vulgaris 2 1 - - - 1
S. enteritidis 6 4 “ - 1 1
S. arizonae 3 3 — — — -
hatchling P. vulgaris 2 2 - - - -
(NT)*
TREATED
egg C. freundii 4 4 - - - -
homogenate P. rettgeri 2 2 - - -
(EH) Morganella
morganii 3 3 - - - -
egg shell C. freundii 9 9 - - - -
(ES) P. vulgaris 1 1 - - -
Pseudomonas spp 5 — — 2 1 2
hatchling C. freundii 9 - 3 3 1 2
excretion P. vulgaris 12 - 4 3 5
assay P. rettgeri 1 - - — 1 —
(EA) M. morganii 5 2 2 1
•Data and isolates for this table was kindly provided by Dr. R.J. 
Siebeling
'’Number of isolates exhibiting MIC at this level 
•Total number of isolates tested 
JFrom adult female 
•From nontreated eggs
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gentamicin are routinely isolated from the gentamicin dip 
solution following treatment of large numbers of eggs (A. 
Prabhakaran, personal communication). The possibility that 
resistant Pseudomonas spp are introduced to the egg upon 
gentamicin treatment remains to be explored. Each of the 27 
enteric strains isolated from turtles hatched from treated 
eggs (i.e., hatchling excretion assay) were resistant (MIC of
12.5 jug/ml or greater). These findings support the idea that 
gentamicin resistant enteric bacteria, uncommon in the 
bacterial population prior to treatment, were selected by 
treatment with the antibiotic.
II. Analysis of mutationallv-derived gentamicin resistance.
The role of spontaneous resistance to gentamicin was 
examined following mutant selection on gentamicin. The 
frequency at which resistant colonies of C. freundii EH-3 
were detected on L agar containing 10 jig/ml gentamicin was 1 
per 108 cells plated. Spontaneous mutants derived from 
sensitive strains were not observed when transferred from L 
agar to L agar supplemented with 20 jig gentamicin/ml or 
greater. This finding suggests there is no single mutation 
that imparts gentamicin resistance above 10 jig/ml. Highly 
resistant mutants could be produced by serially transferring 
gentamicin resistant mutants to incrementally higher 
concentrations of the antibiotic. The maximum level of 
resistance observed for spontaneous mutants derived from C. 
freundii sensitive strains was 300 jtg/ml (Table 2). In a
TABLE 2
MIC values (pg/ml) corresponding to mutationally-derived resistance
Resistance*
Gm Km Nm
Isolate Ib Fc I F I F
C. freundii EA-2 100 >104 25 500 12.5 125
EA-3 100 >104 25 500 25 250
EH-3 0.39 300 6 100 12 50
P. vulgaris NS-4 100 >104 50 200 50 100
EA-6 100 >104 25 200 25 100
NT-1 0.39 500 25 100 25 200
NT-2 0.39 500 25 100 25 100
‘MIC values measured for aminoglycosides tested: Gm, gentamicin; Km,
kanamycin; Nm, neomycin
bInitial MIC value prior to mutant selection
®Final MIC value after multiple rounds of selection for gentamicin resistance
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similar manner, P. vulgaris mutants with MIC values of 500 
I*tg/ml were selected from sensitive strains. When selection 
for spontaneous mutation was used with intrinsically- 
resistant organisms, mutants were isolated which grew in the 
presence of 2 0-50 mg gentamicin/ml in agar medium (i.e., a 
concentration approaching the functional solubility of 
gentamicin).
Following six consecutive transfers of resistant mutants 
to L agar without gentamicin, gentamicin MIC values were 
equivalent to MIC values prior to this transfer. This 
finding demonstrates that inheritable genetic changes and not 
adaptation were responsible for the resistance. Cross 
resistance to heterologous aminoglycosides, such as kanamycin 
and neomycin, was observed prior to selection. Increased 
levels of cross resistance occurred during selection of 
spontaneous mutants resistant to gentamicin (Table 2).
Ill. Plasmid isolation from bacterial strains.
MICs against seven antibiotics were determined for 
selected isolates (Table 3) prior to examination for 
plasmids. The levels of resistance to antibiotics other than 
gentamicin varied among these isolates. In Citrobacter spp, 
gentamicin resistance correlated with erythromycin and 
kanamycin resistance. In Proteus spp, gentamicin resistant 
strains were also resistant to ampicillin and erythromycin. 
It was possible that gentamicin resistance was associated 
with a resistance plasmid. To test for a correlation between
TABLE 3
MIC values (/jg/ml) for selected isolates tested against seven antibiotics
Antibiotic*
Isolate Gm Km Nm Sm Ap Em Cm
C. freundii EA-2 100 25 12.5 100 50 100 0.3
EA-3 100 25 25 100 12.5 100 0.3
EH-3 0.3 6.2 12.5 100 12.5 50 0.3
P. vulgaris NS-4 100 50 50 50 100 100 0.3
EA-6 100 25 50 25 100 100 0.3
NT-1 0.3 25 25 12.5 12.5 50 0.3
NT-2 0.3 25 25 12.5 12.5 50 0.3
*Gm, gentamicin; Km, kanamycin; Nm, neomycin; Sm, streptomycin; 
Ap, ampicillin; Em, erythromycin; Cm, chloramphenicol
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gentamicin resistance and plasmid content, selected 
gentamicin-sensitive and gentamicin-resistant strains of C. 
freundii, P. vulgaris and S. enteritidis were examined for 
the presence of plasmids (Table 4). Plasmids were detected 
in 3 of the 7 resistant C. freundii, 2 of the 3 sensitive C. 
freundii, 2 of the 5 resistant P. vulgaris. Neither the two 
sensitive P. vulgaris nor the 14 resistant S. enteritidis 
contained demonstrable plasmids. Therefore, plasmids were 
found in 5 of the 26 resistant strains tested and in 2 of the 
5 sensitive strains tested. This suggests that plasmids are 
not the only source of resistance in the turtle population. 
These plasmids were transformed into E. coli DHSaMCR, and 
transformants were plated on gentamicin. It did not appear 
that these plasmids conferred gentamicin resistance since no 
gentamicin-resistant transformants were obtained.
IV. Isolation of a gentamicin resistance recrion from
Citrobacter freundii. Proteus vulgaris, and Salmonella
enteritidis.
Resistant C. freundii, P. vulgaris, and S. enteritidis 
(MIC 100 jig/ml) lacking demonstrable plasmids were used to 
isolate the gentamicin resistance gene. Plasmid pMAB30l, a 
13.6 kb recombinant plasmid encoding gentamicin resistance, 
was the smallest of two recombinants isolated from 
experiments using chromosomal DNA of C. freundii EA-3. A 
physical map which identifies restriction sites is shown in 
Figure 2. The only recombinant plasmid isolated from C.
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TABLE 4
Plasmid content for selected isolates as a function 
of gentamicin resistance
Strain MIC* Plasmid Content*1
Citrobacter freundii EA-2 100 _
EA-3 100 -
EA-20 50 +
EA-30 25 -
EA-10 50 -
EA-40 100 +
EA-12 25 +
ES-1 0.3 -
EH-3 0.3 +
CS-5 0.3 +
Proteus vulgaris EA-60 100 —
EA-6 100 +
EA-80 100 -
EA-90 50 -
NS-4 100 +
NT-1 0.3 -
NT-2 0.3
Salmonella enteritidis Hka 100 _
Hkb 100 -
Hkc 100 -
Hkd 100 -
Hke 100 -
Hkf 100 -
SE-1 100 -
SE-2 100 -
SE-3 100 -
SE-4 100 -
SE-5 100 -
SE-6 100 -
SE-7 100 **
•Minimum inhibitory concentration in /ig/ml
t»i_« denotes no plasmids observed while "+" denotes at least
one plasmid observed
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Figure 2. Schematic representation of recombinant plasmids 
containing gentamicin resistance gene from chromosomal DNA 
of Citrobacter freundii strains EA-2 and EA-3. Physical 
maps of initial clones pMAB201 and pMAB301 are shown. 
Cleavage sites for restriction enzymes, where mapped, are 
indicated as follows, Clal, C; EcoRI, El; EcoRV, EV; 
Jfindlll, H; PstI; P; Sail, Sa; and SspI, Ss. Plasmids 
pMAB201 and pMAB30l were used to ultimately generate 
plasmids pMAB222, pMAB232, and pMAB3 02. Other symbols:
, vector DNA; DNA containing the gentamicin
resistance gene region; and ------, other insert
(chromosomal) DNA.
El
pMAB201 
27 kb
221 
7 .9  kb
EV
Ss
231 
7 .2  kb
EV
Ss
Sa
EV
PMAB301 
13 .6  kb
PM AB222 
pM AB232
5 .0  kb
:ev
H
PM AB302
5 .0  kb
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freundii EA-2 DNA (pMAB201) that encoded gentamicin 
resistance contained a 24.4 kb insert. E . coli transformants 
carrying pMAB201 or pMAB3 01 exhibited MIC values of 100 
/xg/ml, a level equivalent to the parent isolates (Table 5) . 
The gentamicin resistance gene was subcloned from pMAB201 as 
a 5.2 kb ifindlll-generated fragment (pMAB221) or a 4.8 kb 
SalI-generated fragment (pMAB231). Digestion of pMAB221 with 
Sail, followed by ligation to circularize the plasmid, 
produced a 5.0 kb plasmid pMAB222. Similarly, Hindlll 
digestion of pMAB23l and ligation generated the 5.0 kb 
plasmid pMAB232. Plasmids pMAB222 and pMAB232 were 
indistinguishable. The physical maps of each plasmid (Figure 
2) demonstrated a 2.3 kb Sall-Hindlll restriction fragment 
which correlated with gentamicin resistance. A 2.3 kb 
Jfindlll-Sall fragment from pMAB301 was subcloned into 
HindUl-Sall digested pUC19 (generating pMAB302) to determine 
if it contained a gentamicin resistance gene. The resulting 
E. coli subclones had gentamicin MIC values of 100 /xg/ml.
Two plasmids, pCLG41 (4.1 kb) and pCLG42 (6.4 kb), 
contained a gentamicin resistance gene cloned from 
chromosomal DNA of P. vulgaris NS-4 DNA (MIC 100 /xg/ml) . 
The two recombinant plasmids carrying a gentamicin resistance 
gene from P. vulgaris EA-6 were pCLG61 (5.2 kb) and pCLG62 
(4.1 kb). Plasmids pMABlOO (10.2 kb) and pMAB400 (30.36 kb) 
were obtained from the chromosomal DNA of S. enteritidis 
SE-2 and SE-3 (MIC 100 /xg/ml), respectively. E. coli
TABLE 5
MIC values (A/g/ml) of Escherichia coli DH5aMCR strains 
containing plasmids pMAB201, pMAB30l, and their derivatives
Antibiotic*
Strains (plasmid) Gm Nm Km Sm
DHSaMCR 1.5 6.2 6.2 12.5
DHSaMCR(pUC8) 6.2 6.2 12.5 12.5
DH5aMCR(pMAB201) 100 12.5 6.2 3.1
DH5aMCR(pMAB301) 100 12.5 6.2 6.2
DH5aMCR(pMAB222) 100 6.2 6.2 NDb
DHSaMCR(pMAB232) 100 3.2 6.2 ND
DHSaMCR(pMAB302) 100 6.2 6.2 ND
■Gm, gentamicin; Km, kanamycin; Nm, neomycin; Sm,
streptomycin
'’ND, not done
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transformants carrying these plasmids exhibited MIC values of 
100 /xg/ml.
V. Comparison of the gentamicin resistance fragments from 
C. freundii. p. vulgaris and S. enteritidis.
The physical maps of the P. vulgaris and S. enteritidis 
insert fragments are aligned with the 2.3 kb insert of 
pMAB222 in Figure 3. There was a region of insert DNA 
conserved among these plasmids. Figure 3 shows a 900 bp 
EcoRV-Sall fragment is common to plasmids pMAB222, pCLG42, 
and pMABioo. The FcoRV-Clal and Clal-Clal fragments of 
pCLG41, pCLGL61, and pCLG62 are comparable to those in 
pMAB222. However, the Clal-Sall fragment of pCLG41, pCLG61, 
and pCLG62 were different than that of pMAB222. This 
fragment was approximately 100 bp shorter in pCLG41 and 100 
bp longer in pCLG61. The SalI site was absent in 
pCLG62•
Plasmids PCLG41, PCLG42, pCLG61 and pCLG62 conferred 
high-level gentamicin resistance (MIC 100 /xg/ml) to E . coli. 
Therefore, the differences in the insert DNA of the separate 
plasmids did not affect gentamicin resistance. It appears 
that a gentamicin resistance gene was present on these DNA 
fragments.
VI. Location of a gentamicin resistance gene in plasmid 
PMAB222 by deletion analysis.
By endouclease restriction of pMAB222 using single or 
double digests, regions of the 2.3 kb Hindlll-Sall insert
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Figure 3. Restriction analysis of recombinant plasmids from 
Citrobacter freundii, Proteus vulgaris, and Salmonella 
enteritidis. Physical maps of the insert regions of pMAB222, 
pCLG constructs, and pMABlOO, aligned according to common 
regions, and sizes are shown. The restriction endonuclease 
cleavage sites are the same as those indicated for Figure 2. 
The sites in parentheses are vector sites. The bar indicates 
100 bp.
PCLG42
pCLG61
pMAB222 _____
2-3 kb H Ss EV EV C C Sa
pCLG41 |__■_____________ |____l
1 .4  kb (HjEV EV c  C Sa (El)
\— I----- 1----------H H
3-7 kb (H) Ss EV EV C C Sa (E|)
2.5 kb ( t y SaC ss EV EV C C (Sa)
pCLG62
1.4  kb (HjEV EV c  C fa )
PS °  i-------------1--- \--------1— fc----- 1--------- 1— //—i
5-5 kb h Ss EV EV c C Sa H
100 bp
were deleted (Figure 4) . The effect of each deletion on the 
expression of gentamicin resistance in E. coli was measured 
by MIC assays, and the location of the gentamicin resistance 
gene was determined. Following deletion of the Jfindlll-SspI 
fragment, which generated pMAB222-S7, no decrease in the 
level of gentamicin resistance was detected (i.e., the MIC 
value was 100 /xg/ml) . Therefore, the gene was not located in 
the HindlXl-Sspl region. Plasmid pMAB222-L6 conferred a 
level of resistance of 3.1 /xg/ml, indicating the 1.6 kb 
SspX-SalX insert contained at least a portion of the fragment 
required for gentamicin resistance. The MIC value (100 
/xg/ml) for E. coli containing the deletion clone pMAB222-23 
indicated the EcoRV-EcoRV fragment was not required for 
gentamicin resistance.
Further deletions were made within the 1.6 kb region in 
pMAB222—13 (MIC 6.2 /xg/ml) and pMAB222-32 (7.8 /xg/ml).
Analysis of each plasmid indicated the 500 bp ClaX-SalX 
fragment contained part of the resistance gene since a 
deletion of this region eliminated gentamicin resistance. 
Deletion of the 1.4 kb ffindlll-FcoRV region, as shown in 
pMAB900, had no measurable effect on the level of resistance. 
Comparison of the restriction maps of these deletion clones 
suggested that only the EcoRV-Sall fragment was required for 
gentamicin resistance at a level of 100 /xg/ml.
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Figure 4. Deletion analysis of pMAB222 insert and
corresponding MIC values (/ig/ml) for deletion clones. To
locate the gentamicin resistance gene from chromosomal DNA of 
C. freundii EA-2, deletions were made within the 2.3 kb 
insert of pMAB222. Cleavage sites for restriction enzymes are 
indicated as follows: Cial, C; EcoRV, E; Hindlll, H; Sal I, 
Sa; and Sspl, Ss. Specific deletions made by digestion with
these enzymes are indicated by gaps in the solid lines. The
MIC values (/ng/ml) conferred to E. coli by the resulting 
subclones are indicated. The bar represents 100 base pairs.
MIC
pMAB222 I----------------------------------- ^ --------+■-----------------------------------------------------------------------^  100
H Ss EV EV C C Sa
pMAB222-S7 J ------------------------------------------------------------------------------------ 1 100
Ss Sa
pMAB222-L6 1----------------------------------- jj .  3 -1
H
pMAB222-13 »— ---------------------------------------------------------------------* £--------------------------- 1 6 2
H C C Sa
pMAB222-32 * " "  ..........     "   j , 0-8H C
pMAB222-23 h j!v  EV Sa
pMAB900 >-----------------------------------------------------1 100
M EV Sa
100 bp
ui
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VII. Level of expression of gentamicin resistance as a 
function of c o p v  number and host background.
To determine the orientation of transcription, the 900 
bp EcoRV-Sall fragment was purified from pMAB222 and cloned 
into Smal-Sall digested pUCl8 and pUCl9 to generate pMAB901 
and pMAB902, respectively. Gentamicin resistance was 
conferred to E. coli by pMAB901 constructs only (i.e., the 
MIC value was 100 /xg/ml). Transformants containing pMAB902 
remained gentamicin sensitive (MIC 0.3 /xg/ml). This 
indicates no promoter exists on the EcoRV-Sall fragment and, 
based on the orientation of the vector-encoded lac promoter, 
the gentamicin resistance gene is transcribed in the 
direction from the EcoRV site toward the Sail site.
It is possible that expression of the gene is limited at 
the level of transcription or translation. To determine 
whether the level of transcription was affected, we cloned 
the EcoRV-Sall fragment into plasmid pARV41, which contains 
a strong SP82 promoter (Achberger et al., 1982) used for high 
levels of gene expression. E. coli transformants carrying 
the resulting plasmid, pMAB905, had MIC values of 100 /xg/ml. 
This indicated that the level of resistance was not limited 
by transcription.
To determine whether gene dosage affected the level of 
gentamicin resistance, the resistance gene region was cloned 
into plasmids of different copy number (Table 6) . The 2.3 kb 
Hindlll-Sall fragment was cloned into pMAK705 to generate 
pMAB2300 with a predicted copy number of 5. This construct
TABLE 6
MIC values (pg/ml) of gentamicin measured for 
Escherichia coli strains as a function of 
plasmid copy number
Strain Plasmid
Construct
Vector” Copy #b MIC
DHSaMCR . 1.5
- pUC19 200-300 1.5
PMAB222 pUC19 200-300 100
PMAB902 pUC19 200-300 3.2
— pUC18 200-300 1.5
PMAB901 pUC18 200-300 100
- pBR322 30-60 1.5
PMAB903 pBR322 30-60 100
pMABlOO pBR322 30-60 100
— pMAK705 5 1.5
pMAB2300c PMAK705 5 100
____ _______
pMAB2300d pMAK705 1 100
construct
bCopy number per chromosome for each vector 
inferred for constructs containing these vectors; 
copy number of the chromosome = 1
*Strain growing at 30°C; plasmid not integrated into 
chromosome
dStrain growing at 42°C; plasmid construct integrated 
into chromosome
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was subsequently integrated into the chromosome of E. coli 
DH5aMCR giving a copy number of l. The 2.3 kb fragment was 
also cloned into pBR322 to generate pMAB904. The level of 
gentamicin resistance in E. coli transformants carrying 
pMAB2300 as a free plasmid, pMAB2300 chromosomally-integrated 
or pMAB904 was equivalent to that conferred by the high copy 
number plasmid pMAB222 (Table 6). Thus gene dosage did not 
have an effect on the level of resistance.
We were interested in studying the level of gentamicin 
resistance that could be obtained by the combination of a 
single step mutation with plasmid encoding gentamicin
resistance. Plasmid pMAB222 was transformed into gentamicin- 
sensitive C. freundii EH-3 and a spontaneous mutant of C. 
freundii EH, called EH-301 (MIC 6.2 /xg/ml) . The MIC value of 
C. freundii EH-3 (pMAB222) was 50 /xg/ml, while that for C. 
freundii EH-301(pMAB222) was 400 /xg/ml (Table 7) . This 
indicated the combination of mutations and gene-encoded 
resistance is not additive but increased in fold increments.
VIII. Protein lableing and analysis.
The protein products encoded by plasmid pMAB222 and the 
deletion plasmids were labeled by the "maxicell" method as 
described in Materials and Methods. Deletion plasmids
carrying gentamicin resistance analyzed in this procedure 
were pMAB222-S7 and pMAB222-23. Plasmid pUC19 was included 
to aid in identification of labeled products from the vector 
and bacterial host background. The labeled products were
TABLE 7
MIC values (/jg/ml) of Citrobacter freundii spontaneous mutants 
carrying recombinant plasmid pMAB222
Strain(plasmid) MIC*
C. freundii EH-3 0.3
EH-3(pMAB222) 50
EH-301 6. 2b
EH-301(pMAB222) 400c
•Minimum inhibitory concentrations measured against gentamicin 
‘MIC value after one-step spontaneous mutation
•MIC value of C. freundii EH-301 mutant transformed with pMAB222
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separated by polyacrylamide gel electrophoresis and 
visualized by autoradiography (Figure 5) . A labeled high 
range molecular weight standard was used to estimate the size 
of the proteins unique to the recombinant plasmids.
A 32,000 Da protein was found only in the samples 
obtained from recombinant plasmids encoding gentamicin 
resistance. These samples are shown in lanes C through F and 
lane H. This protein was not produced by pMAB222-32, a 
deletion clone not encoding gentamicin resistance (Figure 5, 
lane G). Therefore a 32,000 Da protein was encoded by the 
900 bp EcoRV-Sall fragment imparting gentamicin resistance. 
The minor polypeptides migrating above and below the 29,000 
Da and the 32,000 Da proteins were chromosomally-encoded 
proteins produced from E. coli CSR603 cells which survived 
the ultraviolet irradiation during the preparation of 
maxicells.
IX. Southern blotting and hybridization.
Chromosomal DNA from gentamicin-resistant and 
gentamicin-sensitive strains of C. freundii, P. vulgaris, and 
S. enteritidis were screened by Southern blotting and DNA 
hybridization using the insert of pMAB222 as a probe (Figure 
6) . Since the gentamicin resistance gene was contained on a 
Hindi 11-Sal I fragment in all C. freundii and most P. vulgaris 
clones, all DNA samples from these bacteria were digested 
with the Hindlll and Sail prior to analysis, similarly, s. 
enteritidis DNA was digested with HindiII or ScoRI. Uncut
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Figure 5. Plasmid-directed protein synthesis. Proteins 
encoded by gentamicin-resistant and gentamicin-sensitive 
constructs were analyzed by the maxicell labeling technique. 
The autoradiogram of radioactively-labeled proteins is shown. 
Sizes of protein standards in lane A are listed. Samples 
analyzed are indicated as follows : B, pUCl9; C, pMAB221; D,
pMAB222; E, pMAB222-S7; F, pMAB222-23; G, pMAB222-32; and H, 
pMAB900. The gentamicin resistance gene product, indicated 
as 32,000 Da is the major upper band in all samples except A, 
B, and G.
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Figure 6. DNA hybridization using pMAB222 as a probe. The 
autoradiogram of DNA hybrids is shown. Chromosomal DNAs, 
which were digested with Jfindlll and Sail, are indicated as 
follows: lane 1, C. freundii EH-3; lane 2, C. freundii EA-2;
lane 3, P. vulgaris NT-1; lane 4, P. vulgaris EA-6; lane 5, 
P. vulgaris NS-4; lane 6, S. enteritidis Hka; lane 7, S. 
enteritidis SE-1 digested with tfindlll; lane 8, S. 
enteritidis SE-2 digested with FcoRI; lane 9, S. enteritidis 
ATCC; lane 10, pMAB222 Hindlll-SalI digest; lane 11, pMAB222 
uncut; lane 12, pCLG62; lane 13, pCLG41; and lane 14, 
pMABlOO.
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pMAB222 (lane 11) and pMAB222 HindiII-SalI digest (lane 10), 
were included as positive controls. C. freundii EA-2 
chromosomal DNA, from which the gentamicin resistance gene in 
pMAB222 was obtained, showed the expected homology (lane 2). 
The chromosomal DNA from gentamicin-sensitive C. freundii 
EH—3 exhibited no hybridization (lane 1).
Similarly, chromosomal DNA of gentamicin-sensitive P. 
vulgaris NT-1 (MIC 0.3 (xg/ml) did not contain DNA homologous 
to the gentamicin resistance gene (lane 3). P. vulgaris DNA 
from resistant strains EA-6 and NS-4 (lanes 4 and 5, 
respectively) and recombinant plasmids derived from this DNA, 
pCLG62 and pCLG41 (lanes 12 and 13) revealed homology with 
the C. freundii probe. Salmonella enteritidis SE-2, SE-3, 
and clone pMABlOO also contained DNA homologous to the probe 
(lanes 7, 8, and 14 respectively).
Several other gentamicin-sensitive and gentamicin- 
resistant strains of C. freundii, P. vulgaris, and S. 
enteritidis were also screened by hybridization. As expected 
all of the six gentamicin sensitive strains tested did not 
contain DNA homologous with this gentamicin resistance gene. 
Sixteen of the twenty-six gentamicin resistant strains 
contained chromosomal DNA homologous with the C. freundii 
probe. All of the 7 resistant C. freundii and all of the 5 
resistant P. vulgaris strains contained homologous resistance 
gene(s) . Hybridization data for several P. vulgaris are shown 
in Panel 1 of Figure 7. Only 4 of the 14 S. enteritidis 
strains, however, showed homology with the pMAB222 probe.
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Figure 7. DNA hybridization of the gentamicin resistance 
gene from pMAB222 to Proteus vulgaris and Salmonella 
enteritidis DNAs. All DNAs were digested with Hindlll and 
Sal I prior to hybridization analysis.
Samples shown in Panel 1 are indicated as follows: A, 
pMAB2 01; B, C. freundii EA-2; C, C. freundii EH-3; D, P. 
vulgaris NS-4; E, P. vulgaris EA-6; F, P. vulgaris EA-110; 
G, P. vulgaris EA-80; H, P. vulgaris NT-1; I, pCLG41; J, 
pCLG61.
Panel 2: A, pMAB222; B, E. coli DH5aMCR; C, S.
enteritidis SE-l; D, £. enteritidis SE-2; E, S. enteritidis 
SE-3; F, S. entertidis SE-4; G, S. enteritidis SE-5; H, S. 
enteritidis SE-6; and I, S. enteritidis SE-7.
-  • * *
The S. enteritidis strains, sources and hybridization data 
are listed in Table 8. Hybridization of some of these 
strains are shown in Figure 7, Panel 2. Strains SE-1, SE- 2, 
and SE-3 hybridized with the probe and shared a similar 
hybridization pattern (lanes 3-5 respectively). S.
enteritidis SE-4 showed a different hybridization pattern 
(lane 6) . However, S. enteritidis strains Hka (Figure 6, lane 
6), Hkb, Hkc, Hkd, Hke, Hkf, Hkg, SE-5 (Figure 6, Panel 2, 
lane 7), SE-6 (lane 8), and SE-7 (lane 9) showed no
detectable homology with pMAB222.
X. Aminoglycoside acetvltransferase specific activity.
To explore the relationship between the level of
gentamicin acetyltransferase specific activity (GAT) and 
bacterial growth, acetyltransferase activity was determined 
for samples taken at various times during growth (Figure 8, 
Panels A and B) . With C. freundii EA-2 (Panel A) , as well as 
with E . coli(pMAB222) transformants (Panel B) , gentamicin 
acetyltransferase activity peaked during late exponential 
phase. Since the level of gentamicin acetyltransferase 
specific activity changed dramatically with the stage of 
growth and it was impractical to repeat growth curves for all 
strains, three growth points were chosen to assay for
activity. Other strains assayed, the density at which 
cultures were taken, and gentamicin acetyltransferase
specific activities are listed in Table 9.
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TABLE 8
Summary of DNA hybridization and GAT activity for 
gentamicin resistant salmonella enteritidis 
isolated from different turtle farms
Strain Source* Hybridization* GAT*
Hka HK 0.6
Hkb HK — 2.6
Hkc HK - 0.0
Hkd HK — 0.0
Hke HK - 0.4
Hkf HK — 0.3
Hkg HK - 0.9
SE-1 BK + 1.5
SE—2 BK + 6.6
SE-3 BK 2.0
SE-4 AM + 1.4
SE—5 AM - 14.5
SE—6 AM - 0.0
SE—7 RK
"
4.4
b"+" indicates presence of gentamicin resistance 
gene homologous with C. freundii aacC gene;
indicates absence of homologous gentamicin 
resistance gene
cGentamicin acetyltransferase specific activity 
measured as nmol gentamicin acetylated/min/mg of 
protein at 25°C
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Figure 8. Growth curves and corresponding GAT values for 
Citrobacter freundii EA-2 and Escherichia coli pMAB222. 
Gentamicin acetyltransferase activity was determined as a 
function of growth. In Panel A, the closed circles represent 
points on the growth curve of C. freundii EA-2, while the 
closed triangles indicate the gentamicin acetyltransferase 
specific activity of extracts obtained from cells at the 
corresponding stage of growth. In Panel B, the closed 
circles represent points on the growth curve of E. coli 
(pMAB222) and the closed triangles indicate corresponding 
gentamicin acetyltransferase specific activities.
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TABLE 9
Gentamicin acetyltransferase specific activity measured 
as a function of growth
GAT*
Strain(plasmid) 80-100 160-180 240-280
Klett units Klett units Klett units
E. coli DH5aMCR 0.0 0.0 0.0
E. COli DH5orMCR(pMAB222 ) 3.3 3.7 13.6
E. coli DH5aMCR(pCLG62) 2.0 1.6 1.6
E. coli OHSaMCR(pMABlOO) 1.0 2.0 4.1
C. freundii EA-2 6.3 8.5 5.6
P. vulgaris EA-6 1.1 1.1 1.2
S. enteritidis SE-2 4.7 2.6 6.6
s. enteritidis Hka 0.0 0.1 0.6
s. enteritidis SE-5 13.6 14.5 1.6
s. enteritidis SE-7 4.4 1.0 0.2
•Gentamicin acetyltransferase specific activity measured in nmol
gentamicin acetylated/min/mg of protein at 2S°C
The control extract from E. coli DH5aMCR showed no 
acetylation of gentamicin. E. coli pMAB222 extract showed 
the greatest gentamicin acetylating activity among all of the 
clones tested. E. coli carrying pCLG62 or pMABlOO had 
comparable, but lower, activity. The highest specific 
activity for E. coli carrying pMAB222, pCLG62 or pMABlOO was 
obtained when cultures were grown to 240 Klett units. Among 
parent strains from which clones were obtained, C. freundii 
EA-2 extract (from 280 Klett units) had the greatest 
acetylating activity. S. enteritidis SE-2 extract had 
acetylation activity comparable to that for C . freundii EA-2. 
The acetylation activity for P. vulgaris EA-6 appeared to be 
much less than that those for the other parent isolates.
The gentamicin acetylation activities were also 
determined for several other S. enteritidis isolates. 
Strains SE-1, SE-3, and SE-4, which contained chromosomal DNA 
hybridizing with pMAB222, showed activities were comparable 
with that for C. freundii EA-2 extract (Tables 8 and 9) . 
Gentamicin acetyltransferase activity was also tested in 
strains that did not show homology to the cloned gentamicin 
resistance gene (Table 8, Table 9) . Extracts from S. 
enteritidis strains Hka, Hke, Hkf, and Hkg showed weak 
gentamicin acetylation activity compared to C. freundii EA-2. 
S. enteritidis Hkc, Hkd, and SE-6 showed no gentamicin 
acetylating activity. S.. enteritidis Hkb showed activity 
comparable with that for C. freundii EA-2, while strain SE-5 
extract taken at 180 Klett units showed comparable gentamicin
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activity than C. freundii EA-2. S. enteritidis SE-7 extract 
had the highest gentamicin acetylating activity at 100 Klett 
units.
Levels of gentamicin resistance as measured by 
gentamicin acetyltransferase specific activities were 
analyzed as a function of gene copy number. The maximal 
activity observed for E. coli with pMAB222 at 200-300 copies 
per chromosome was 13.6 nmol gentamicin acetylated/min/mg 
protein. This was comparable to the value of 11.6, which was 
observed for E. coli with pMAB2300 at 5 copies per 
chromosome. Therefore, no detectable gene dosage effect was 
associated with this gene.
XI. Substrate profiling and identification of gentamicin
resistance genes.
The correlation between MICs and acetyltransferase 
activities for selected aminoglycosides was analyzed for E. 
coli(pMAB222) and S. enteritidis SE-5. Strain SE-5 was 
chosen since it possesses gentamicin acetyltransferase 
activity but does not contain DNA homologous to the 
gentamicin resistance fragment. For each aminoglycoside 
tested, there appeared to be a direct correlation between 
aminoglycoside acetylation and MIC values (Table 10) . As 
shown in Table 10, E. coli(pMAB222) extract showed strong 
gentamicin acetylating activity, weak kanamycin acetylating 
activity and no neomycin acetylating activity. Because this 
substrate profile agreed with that for aacC2 genes, we
TABLE 10
Comparison of aminoglycoside acetyltransferase activity* and 
respective MIC values (pg/ml) measured for selected strains
Strain(plasmid) GATk MIC NAT' MIC RAT1 MIC
E. coli DH5aMCR(pMAB222) 13.6 100 0.0 6.2 0.1 6.2
S. enteritidis SE-5 14.5 100 1.3 25 3.9 100
‘Acetyltransferase specific activity expressed as nmol of 
aminoglycoside acetylated/min/mg of protein at 25°C 
bgentamicin acteyltransferase activity 
'neomycin acetyltransferase activity 
ikanamycin acetyltransferase activity
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tentatively identified our resistance gene as an aacC2 gene. 
By comparison, S. enteritdis SE-5 extract acetylated 
kanamycin and neomycin at rates higher than those for E. coli 
(pMAB222). It is possible that S. enteritidis contained a 
gene other than an aacC2.
XII. Restriction mapping and nucleotide sequencing.
The sequencing strategy for the C. freundii gentamicin 
resistance gene is shown in Figure 9. The nucleotide 
sequence of the gene and the upstream region are shown in 
Figure 10. One open reading frame of 858 base pairs preceded 
by a Shine-Delgarno ribosome binding site was detected. 
Using the Targsearch computer program (Mulligan et al., 
1984), a potential promoter sequence sharing only 49% 
homology with consensus promoter sequences of E. coli was 
found upstream of the ribosome binding site. The open 
reading frame potentially encodes a protein with calculated 
mass of 30.0 kDa.
The physical map derived by restriction endonuclease 
digestion (Figure 2) agreed with that obtained from the 
nucleotide sequence. The nucleotide sequences of the 250 bp 
Clal fragments from P. vulgaris-derived pCLG62 and S. 
enteritidis-derived pMABlOO (data not shown) shared 100% 
homology with the C. freundii-derived pMAB222 Clal fragment, 
also 250 bp. The G+C content of the gene was 68%, while that 
for the upstream region was 50%. The codon usage index for
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the C. freundii gentamicin resistance gene was 0.03 (Appendix 
B). This suggests the gene is translated inefficiently.
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Figure 9. Sequencing strategy of the gentamicin resistance 
gene from Citrobacter freundii EA-2. The gene and upstream 
region are shown. The heavy arrow above the restriction map 
represents the aacC2 gene and the direction of its 
transcription. The light arrows below the map indicate the 
fragments used for sequence determination and the direction 
in which they were read. Cleavage sites are indicated as 
follows: A, Alul; C, Clal; E, EcoRV; H, tfaelll; M, MspI; SA,
Sail; and S, Sau3AI.
E HS M S M A
100 bp
K * I
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Figure 10. The nucleotide sequence of the gentamicin 
resistance gene from C. freundii EA-2. The ribosome binding 
site is underlined and indicated by SD. The aacC2 coding 
sequences are indicated as follows: C. freundii aacC2, line
1; aacC2b from plasmid pWPH3a from Klebsiella
(Allmansberger et al., 1985), line 2; and aacC2a from plasmid 
pJVOl from Enterobacter (Vliegenthart et al., 1989). The 
start codon at postion 1 and the stop codon at position 287 
are underlined. The one-letter codes for amino acids are 
used.
SD
(1) C,freundii aacC TATTTTAACCAG— ATTC— GATA-------------------------------
(2) aacC2b CCACCATCGGTCAAGCAGCGAGAGGTATAATGTTTGGCAGTTTAGAGGAGATATCGCG
(3) aacC2a AGA-GTAGA— G-TATCT T-------G---- T--------------------
ATG CAT ACG CAG AAG GCA ATA ACG GAG GCG CTT CAA AAA CTC GGA GTC CAA TCC GGT GAC 20
K H T Q A I T E A L Q K L G V Q S G D L
CTG TTG ATG GTG CAT GCC TCA CTT AAA TCG ATT GGT CCG GTC GAA GGA GGA GCG GAG ACG 40
L M V H H A S L K S I G P V E G G A E T
GTC GTC GCC GCG TTA CGC TCC GCG GTT GGG CCG ACT GGC ACT GTG ATG GGA TAC GCA TCG 60
— T
V V A A L R S A V G P T G T V M G Y A S
TGG GAC CGA TCA CCC TAC GAG GAG ACT CTG AAT GGC GCT CGG TTG GAT GAC AAT GCC CGC 80
W D R S P Y E E T L N G A R L. D D N A R
CGT ACC TGG CCG CCG TTC GAT CCC GCA ACG GCC GGG ACT TAC CGT GGG TTC GGC CTG CTG 100
R T W P P F D P A T A G T Y R G F G L L
AAT CAG TTT CTG GTT CAA GCC CCC GGC GCG CGG CGC AGC GCG CAC CCC GAT GCA TCG ATG 120
N Q F L V Q A P G A R R S A H P D A S M
GTC GCG GTT GGT CCG CTG GCT GAA ACG CTG ACG GAG CCT CAC GAA CTC GGT CAC GCC TTG 140
L A E T L V A V G P T E P H E L G H A L
-T-
GGG GAA GGG TCG CCC AAC GAG CGG TTC GTC CGC CTT GGC GGG AAG GCC CTG CTG TTG GGT 160
GT-
G E G S P I E R F V R L G G K A L L L G
GCG CCG CTA AAC TCC GTT ACC GCA TTG CAC TAC GCC GAG GCG GTT GCC GAT ATA CCC AAT 180
A P L N S V T A L H Y A E A V A D I P N
AAA CGG TGG GTG ACG TAT GAG ATG CCG ATG CCT GGA AGA GAC GGT GAA GTC GCC TGG AAA 200
K R W V T Y E M P M P G R D G E V A W K
ACG GCA TCG GAT TAC GAT TCA AAC GGC ATT CTC GAT TGC TTT GCT ATC GAA GGA AAG CAG 220
T A S D Y D S N G I L D C F A I E G K Q
GAT GCG GTC GAA ACT ATA GCA AAT GCT TAC GTG AAG CTC GGT CGC CAT CGA GAA GGT GTC 240
D A V E T I A N A Y V K L G R H R E G V
GTG GGC TTT GCC CAG TGC TAC CTG TTC GAC GCG CAG GAC ATC GTG ACG TTC GGC GTC ACC 260
V G F A Q C Y L F D A E D I V T F G V T
TAT ‘CTT GAG AAG CAT TTC GGA ACC ACT CCG ATC GTG CCT GCG CAC GAA GCC ATC GAG CGC 280
Y L E K H F G T T P I V P A H E A I E R
(1) <C. freundii aacC
TCT TGC GAG CCT TCA GGT TAG AGGCCGTCGAC (2) aacC2b
S C E P S E
DISCUSSION
Gentamicin resistance has been observed among enteric 
isolates from commercial turtle farms since the early 1970s 
(Michael-Marler et al., 1983). In the present study, a survey 
of treated and non-treated sources on one turtle farm 
effectively illustrated this resistance. Isolates from 
treated sources, such as "egg homogenate" and "egg shell", 
were obtained immediately after egg treatment, while bacteria 
were isolated from hatchlings (i.e., hatchling excretion 
assay) one year after treatment. The finding that all 
isolates obtained from hatchling excretion assays were 
gentamicin resistant may be due to the fact that the drug 
remains within the egg at low concentrations post treatment. 
Residual gentamicin selects for gentamicin resistance and 
these organisms populate the young animal. Therefore, the 
number of resistant isolates from nontreated and treated 
sources suggests that gentamicin used in egg sanitation 
procedures selected for resistant organisms which existed in 
the turtle population.
These data provided limited information concerning the 
bacterial source of the gene in this environment. It can be 
speculated that the observed gentamicin resistance originated 
from an organism such as resistant Pseudomonas spp, which has 
been found among gentamicin resistant turtle isolates. The 
presence of these bacteria observed immediately after
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gentamicin dip is consistent with their introduction at this 
stage. It has recently been determined that Pseudomonas spp 
can survive and accumulate in the dip solution with repeated 
use (A. Prabhakaran, personal communication). Although it 
appears that certain gentamicin resistance genes are unique 
to pseudomonads, these genes are often carried on R factors 
(Rubens et al., 1979) and transfer of these genes among 
bacteria is possible. Evidence for the existence of aacC 
genes from Pseudomonas in enterics would support the idea 
that pseudomonads may be the source of the gentamicin 
resistance in the turtle population. We did not, however, 
pursue this analysis due to the relatively high numbers of 
resistant Citrobacter freundii and Proteus vulgaris. In 
addition, these nonpathogenic organisms are more closely 
related to E. coli than is Pseudomonas simplifying 
experimental analysis (Sanderson, 1976). The prevalence of 
these isolates in all samples obtained from the turtle 
population suggested that a major mechanism of gentamicin 
resistance was present within these organisms.
Since plasmids are the most common carriers of antibiotic 
resistance genes in Enterobacteriaceae (Bryan, 1982), it was 
interesting that the majority of resistant isolates in this 
study did not contain any plasmids, while plasmids were 
observed in several gentamicin-sensitive organisms. Plasmids 
obtained from gentamicin-resistant enterics were small and 
did not confer gentamicin resistance to E. coli K-12. in 
addition, the levels of resistance to antibiotics other than
88
gentamicin varied among these isolates. Since no correlation 
between gentamicin resistance and presence of plasmids was 
observed, it was determined that plasmids could not be the 
sole mechanism(s) of gentamicin resistance. We subsequently 
analyzed chromosomal DNA of several gentamicin resistant 
organisms.
I. Chromosomallv-encoded gentamicin resistance.
Gentamicin resistance genes were isolated from C. 
freundii, P. vulgaris, and S. enteritidis isolates. 
Restriction maps of the recombinant plasmids derived from C. 
freundii chromosomal DNA appeared identical, each containing 
a common region of insert DNA. Because these subclones 
conferred a level of gentamicin resistance equivalent to that 
of the original isolates,it appeared that a gene conferring 
gentamicin resistance was obtained from the chromosomal DNA 
of these strains. Although the majority of gentamicin 
resistance genes are carried by R plasmids (Bryan, 1982), 
several of these genes have been cloned from the genomic DNA 
of organisms such as Klebsiella spp (Benveniste and Davies, 
1973a) and Pseudomonas spp (Vliegenthart et al., 1991). 
Therefore, the presence of our gene in chromosomal DNA was 
not unprecedented and may have resulted from incorporation of 
the gene via transposition, homologous recombination, or 
site-specific recombination.
Using the C. freundii gene as the prototype, deletion 
analysis and maxicell labeling were used to characterize the
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location of the gene on the region of insert DNA. 
Restriction mapping suggested that the recombinant plasmids 
obtained from P. vulgaris and s. enteritidis chromosomal 
DNAs were very similar to that of the c .  freundii-derived 
recombinant plasmid pMAB222. Differences in DNA flanking the 
genes did not affect the levels of gentamicin resistance 
measured by MICs. The fact that these plasmids contained a 
conserved region of insert DNA which hybridized with the 
fragment carried by pMAB222 suggests that homologous 
resistance genes were derived from three different genera of 
enteric bacteria. A Clal fragment contained within each of 
these resistance fragments was sequenced. The nucleotide 
sequences were identical, confirming the homology between the 
gentamicin resistance genes from the three sources. The 
transfer of the gene between bacteria was not examined due to 
the presence and apparent stability of the gene within the 
chromosomal DNA.
II. Spontaneous mutation studies.
The calculated frequency of spontaneous mutation observed 
for C. freundii and P. vulgaris and the increased cross 
resistance in gentamicin resistant mutants in this study were 
consistent with results reported for E. coli (Buckel et al., 
1977) . As expected, our data supports the idea that a single 
one-step mutation does not confer a high level of gentamicin 
resistance (Buckel et al., 1977).
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The role of mutationally-derived resistance in the turtle 
population was analyzed. If organisms which carried 
resistance gene(s) acquired spontaneous mutations, the level 
of gentamicin resistance may increase well above that 
imparted by the gene alone. A potential problem was first 
indicated through studies involving mutants derived from 
intrinsically-resistant isolates and naturally-sensitive 
organsisms. The intrinsically-resistant organisms had 
maximum levels of gentamicin resistance greatly exceeding 
those for mutants derived from naturally-sensitive bacteria. 
The difference in the maximum levels of resistance among 
mutants was suggestive of the existence of a resistance gene 
in the intrinsically-resistant isolates. These findings are 
consistent with the subsequent cloning of a gentamicin 
resistance gene.
The possibility of obtaining high level resistance 
through the combination of mutation and genetically-derived 
resistance was directly tested. It was found that a 4-5 fold 
increase in the MIC value could be obtained by a one-step 
mutational event in an organism already possessing a 
resistance gene. Therefore, it appears that the combined 
effect of spontaneous mutation and a gene-encoded resistance 
is multiplicative. This may cause additional problems for 
turtle farmers since the current dip regimen may not be able 
to eliminate these organisms.
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III. Characterization of gentamicin resistance.
Antibiotic inactivation is the most prevalent mechanism 
of gentamicin resistance in Enterobacteriaceae. We began the 
characterization of our gene by assaying for the most common 
type of gentamicin inactivation activity, gentamicin 
acetyltransferase activity. The gentamicin acetylation that 
was observed with cell extracts from gentamicin-resistant E. 
coli transformants suggested that our resistance gene was 
indeed a gentamicin acetyltransferase gene.
The minimum length of the gene, determined by deletion 
analysis as approximately 900 bp, was consistent with the 
sizes of aacC genes, such as aacCl and aacC4, which are 555 
and 834 bp, respectively. The size of our gene was also 
consistent with that of an aacC2 gene from Enterobacter 
(Vliegenthart et al., 1989), which we will call aacC2a, and 
an aacC2 gene from Klebsiella (Allmansberger et al., 1985), 
referred to here as aacC2b. Both of these genes are 858 bp 
in length. In previous studies, the aacC2b gene was 
initially characterized as an aacC3. However, when the 
sequences of this gene and aacC2a were shown to differ at 
only 29 postitions, it was suggested that the aacC3 gene was 
actually an aacC2. Based on substrate profiling (i.e., the 
ability to inactivate specific aminoglycosides) the 
identification of the presumed aacC3 gene as an authentic 
aacC2 gene was confirmed. In addition, the sequence of the 
aacC3 gene from Pseudomonas was recently published
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(Vliegenthart et al., 1991) and shares no significant 
homology with aacC2a or aacC2b.
Initial comparison of the restriction endonuclease map of 
our resistance gene with the mapping data for these aacC2 
genes suggested that the gene isolated in this study was an 
aacC2 gene. This was supported by the fact that the 
nucleotide sequence of our gene was nearly completely 
homologous to that of aacC2b, differing by a base pair at 
only 3 positions. Our sequence was slightly less homologous 
to that of aacC2a, differing at only 31 bp. From the 
nucleotide sequence of our gene, the presumed amino acid 
sequence of the encoded AAC(3) enzyme was derived. We were 
able to calculate the predicted molecular mass. This 
calculated mass of 30,000 Da was consistent with the mass 
determined for AAC(3)-II enzymes encoded by aacC2a and 
aacC2br both of which are 30,000 Da. The size of our 
resistance protein as expressed in maxicells, 32,000 Da, also 
agrees with these values.
By restriction mapping and nucleotide sequencing, we have 
tentatively identified the specific isotype of the encoded 
enzyme as an AAC(3)-II. To confirm this identification, we 
determined the substrate profile of the acetyltransferase. 
Since we detected strong gentamicin acetylation, weak 
kanamycin acetylation, and no neomycin acetylation with the 
resistance protein, we confirmed its identification as an 
AAC(3)-II (Bongaerts et al., 1988). Our data are consistent
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with the fact that acetyltransferase activity is the most 
common type of gentamicin resistance in enteric isolates.
IV. Protein labeling.
The mass of the encoded protein, 32,000 Da, was 
consistent with the mass of 30,000 Da determined for known 
aacC.2-encoded acetyltransf erases (Allmansberger et al., 1985; 
Vliegenthart et al., 1989). The protein was easily 
distinguished from the 29,000 Da vector-encoded p-lactamase 
protein. Minor polypeptides above and below our protein were 
observed on the autoradiogram. These peptides were 
apparently produced from chromosomal DNA which remained 
intact throughout the maxicell procedure (Sancar et al., 
1981). Under ideal conditions, these chromosomally-encoded 
proteins would not be produced. Due to the nonphysiological 
conditions of the maxicell procedure, no conclusion can be 
made about the level of expression of this protein.
V. Acetyltransferase specific activity.
The DTNB assay allowed efficient detection of gentamicin 
acetyltransferase (GAT) specific activity in enteric isolates 
and E. coli transformants. Although detection of
acetyltransferase activity was possible in C. freundii EA-2, 
P. vulgaris EA-6, and S . enteritidis SE-2, it was complicated 
by a significant background rate of acetyl Coenzyme A 
deacetylation in some samples. This made comparison of 
enzyme activities difficult. The rapid change in GAT
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specific activity as a function of growth also complicated 
the analysis. Although activity determinations were measured 
at multiple points during growth, conclusions were limited to 
detection and gross changes in activity. The fact that the 
level of gentamicin acetylation was greatest in late 
exponential growth is consistent with previous findings 
(Williams and Northrop, 1976) and may indicate that enzymes 
levels are highest in this stage.
Since MIC values of parent isolates and E. coli clones 
were equivalent, we expected the observed gentamicin 
acetylation activities to be equivalent. Because these genera 
are closely related, we expected to find comparable 
acetylation activities at corresponding points of exponential 
growth. However, activity levels varied among isolates and 
clones. In addition, no correlation existed between maximum 
activity and a specific point in exponential growth. The 
differences among parent isolates may have resulted from 
background rates of acetyl Coenzyme A deacetylation or the 
levels of endogenous proteases inactivating the 
acetyltransferases. Although codon usage among
Enterobacteriaceae is similar (de Boer and Kastelein, 1986), 
levels of required tRNA isoacceptors may differ significantly 
during specific stages of growth, affecting gene expression.
As expected, the expression of this acetyltransferase 
did not appear to be inducible. Acetylation activities were 
comparable when isolates were grown in L broth with or 
without gentamicin prior to extract preparation. It is
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possible that the gentamicin acetyltransferase must be 
maintained at low levels in resistant organisms in order to 
inactivate the antibiotic before it reaches the ribosome.
Several other observations of AAC(3)-II activity made 
during these studies are noteworthy. The initial part of the 
curve resembled a typical acetylation curve. Aminoglycoside 
acetyltransferase activity was determined using this region. 
The curve leveled off steadily, which may reflect low enzyme 
stability or low reactant concentration. It is also possible 
that acetyltransferase activity of the crude extract was 
inhibited by the acetylated end product or some factor of the 
DTNB assay. However, Benveniste and Davies (1971) used a 
similar assay to measure acetyltransferase activity of 
partially purified enzymes, and they determined that DTNB did 
not inhibit activity. Aminoglycoside concentrations greater 
than O.lmM inhibit the reaction rate of aminoglycoside 
modifying enzymes (Bongaerts and Vliegenthart, 1988). This 
substrate inhibition often produces a false measure of low 
activity against that specific substrate. The concentration 
of gentamicin used in the DTNB assay (5mM) was held constant 
while the amount of enzyme in teh extracts differed. Some 
ratios of enzyme to substrate may have exhibited low 
activity.
Previous studies have shown that the pH optimum for 
AAC(3)-II is 7.5 (Haas and Dowding, 1975). The buffer used 
for the DTNB assay in our study was pH 7.5 and contained 
cofacters possibly required for acetyltransferase activity
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(Chevereau et al., 1974). It is possible that these 
acetyltransferases have a slow turnover rate. In such a 
case, the curve may level off as active sites on the enzyme 
are bound by substrate at a faster rate than the acetylated 
endproducts are released.
The phosphocellulose paper binding assay (Bongaerts and 
Vliegenthart, 1988) eliminates several of these factors. 
Acetylation activity can be detected via enzymatic transfer 
of a radiolabeled molecule from a cofactor to the antibiotic. 
This method, however, can be time-consuming and expensive as 
it requires enzyme purification and the use of radioactively 
labeled compounds. Because we were more interested in the 
detection of activity rather than the comparison specific 
reaction rates, the DTNB assay was used.
VI. The nucleotide sequence of aacC2.
Detailed information on the aacC2 genes from C. 
freundii, P. vulgaris and S. enteritidis was obtained by 
nucleotide sequencing. Even though the sequence for the 
downstream end of the EcoRV-EcoRV fragment does not overlap 
that of the EcoRV-Sall gene, we were able to correctly orient 
these regions. The DNA sequence immediately upstream of all 
aacC2 genes that have been sequenced is highly conserved 
(Allmansberger et al., 1985; Vliegenthart et al., 1989). 
Furthermore, an oligonucleotide containing this sequence has 
been used to amplify aacC2 genes from chromosomal DNA of 
several gentamicin resistant isolates using the polymerase
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chain reaction (E. Achberger, personal communication). 
Therefore we were able to orient the sequence of the upstream 
region without the use of overlapping fragments.
Although a Shine-Delgarno site upstream of the start site 
was present, the upstream region did not appear to contain a 
probable -35 and -10 promoter for the aacC2 gene. A region 
sharing only weak homology with consensus promoter sequences 
was found. Analysis of the nucleotide sequence of our gene 
compared to aacC2 genes revealed remarkable homology. 
However, the upstream regions of these genes showed no 
homology. Insertion sequences similar to those found 
upstream of other aacC2 genes were not identified upstream of 
our aacC2 gene. It is possible that our upstream region 
contains an insertion sequence which has not been identified.
The G+C content of our upstream region, 50%, suggested 
that this DNA was a normal chromosomal constituent of the 
parent isolates. The G+C content of our aacC2 gene at 68%, 
however, was significantly higher than that of the upstream 
region and of most genes found in enteric organisms 
(Sanderson, 1976) . This suggests that the gene did not 
originate in the parent isolates. The high G+C content of 
aacC2 and comparison to codon usage for expression of this 
gene in Streptomyces suggests that the aacC2 gene may have 
originated in actinomycetes.
To analyze this further, the codon bias index of our 
aacC2 gene was calculated (Appendix B) . Since E. coli and C. 
freundii are very closely related, the index could be
calculated for the C. freundii-derived gene based on the 
codon preference of E. coli (de Boer and Kastelein, 1986). 
When compared to the codon usage index of 0.65 for highly 
expressed genes in E. coll, such as Ipp and ompA, the index 
calculated for aacC2, 0.03, was dramatically lower. It is 
highly unlikely that the aacC2 gene would be efficiently 
translated in E. coli and other members of the 
Enterobacteriaceae. The extent of rare codon usage may 
account for the low concentration of aminoglycoside modifying 
enzymes in bacteria which do not produce antibiotics. Codon 
usage may also explain why detectable acetyltransferase 
activities were low and why MIC values never exceeded 100 
/Ltg/ml.
Use of nonpreferred codons in the open reading frame of 
this gene may also explain why no dosage effect was observed 
with our gene. The copy number of recombinant plasmids 
carrying our aacC2 gene had no apparent effect on the level 
of gentamicin resistance or the acetylation activity. 
Recombinant plasmids containing high copy number vectors, 
such as pUC19, moderate copy number vectors, such as pBR322, 
or low copy number vectors, such as pMAK705, had equivalent 
MICs and comparable acetyltransferase activities. 
Furthermore, the level of expression was not changed when a 
single copy of the gene was integrated into the chromosome of 
gentamicin sensitive E. coli or when the gene was cloned 
behind a strong promoter. Whether one copy or two hundred 
copies of the gene were present, the MIC value did not exceed
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100 /xg/ml. This evidence suggests that the lack of gene 
dosage effect is due to poor translation of the protein as a 
result of limiting amounts of essential nonpreferred tRNAs in 
these organisms. Apparently the low levels maintained in the 
cell are sufficient for gentamicin resistance in their 
natural environment.
The fact that the sequences of the 250 bp Clal fragments 
from C. freundii, P. vulgaris, and S. enteritidis were 
identical suggests the three aacC2 genes were highly 
homologous and closely related evolutionarily. The strong 
homology suggests that a gentamicin resistance gene may have 
been transferred in the turtle population. The sequence of 
our aacC2 gene shared remarkable homology with that of aacC2b 
gene, differing by only 3 bp.
Comparison of the nucleotide sequence of a gene which is 
present in different organisms may reveal important 
information concerning the evolutionary relatedness of those 
genes. Because our aacC2 sequence differs from that of 
aacC2b by only 3 bp, it appears that the genes are closely 
related. The fact that the genes were both isolated inside 
the United States supports this idea. Two of the differences 
found did not appear to be significant since they did not 
lead to an amino acid replacement. The third difference, 
however, leads to a change in the amino acid sequence. Where 
there is an asparagine residue at position 141 of the protein 
for the aacC2b gene, there would be an isoleucine in the 
amino acid sequence derived from our aacC2 nucleotide
10 0
sequence. It is not known how the presence of a polar 
uncharged amino acid (aacC2b) or a hydrophobic uncharged 
amino acid (our aacC2) affects activity. Because both aacC2 
genes conferred high level gentamicin resistance, it did not 
appear that this single amino acid change had a profound 
effect on enzyme activity. It is probable that this did not 
occur in an active site or binding site. Similarly the 14 
amino acid differences between our gene and the aacC2a gene, 
which was isolated in the Netherlands (Vliegenthart et al., 
1989), did not appear to affect enzyme function.
VII. Detection of gentamicin resistance in the turtle
population.
Hybridization using the gentamicin resistance gene from 
pMAB222 proved useful in analyzing the extent of this 
resistance in the bacteria found in the turtle population. 
Not only were homologous resistance genes cloned from three 
genera of enteric organisms, homologous fragments were 
detected in all gentamicin resistant strains of C. freundii 
and P. vulgaris and in several S. enteritidis strains. Since 
the majority of the S. enteritidis isolates, however, did not 
contain aacC2, it appears that this gene was not the only 
source of resistance in the turtle population.
The faint signals and banding patterns observed on the 
autoradiogram of samples from parent strains (Figure 6, lanes 
2, 4, 7, and 8; Figure 7, Panel A, lanes 4, 5, 6, and 7) may 
be due to cross hybridization or the presence of weakly
1 0 1
homologous genes. it is possible that the multiple bands 
observed in some samples are due to enzyme "starring" 
activity or partial digestion of sample DNA prior to 
hybridization. The DNA purity or salt concentration may have 
also affected restriction endonuclease digestions. The 
hybridization analysis coupled with the assays for the 
presence aminoglycoside acetyltransferase activity provided 
an estimation of the minimum number of gentamicin resistance 
mechanisms in the turtle population. The absence of 
gentamicin acetylation activities in resistant S. enteritidis 
strains that did not hybridize to the aacC2 gene (e.g., Hkc, 
Hkd, and SE-6) indicated the presence of a second gentamicin 
resistance gene. These S. enteritidis genes may encode other 
aminoglycoside modifying enzymes such as phosphotransferase 
APH(31) or nucleotidyltransferase (ANT(2"), which are not 
homologous with AAC(3)-II (Shannon et al., 1982). It is also 
possible that the gentamicin resistance observed in these 
isolates was mutationally-derived.
A third gentamicin resistance gene may be found in S. 
enteritidis strains, such as Hkb, SE-5 and SE-7. No homology 
was observed to the aacC2 gene even though gentamicin 
acetyltransferase activity comparable to or higher than that 
of C. freundii EA-2 was demonstrated. It appeared that these 
Salmonella contained a gentamicin acetyltransferase gene 
other than an aacC2 gene. To test this we assayed S. 
enteritidis SE-5 for kanamycin and neomycin acetylation 
activities. Significant levels of kanamycin and neomycin
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acetylation were observed. The MIC values of this strain 
against kanamycin and neomycin (100 /xg/ml) were consistent 
with acetyltransferase activities observed. This profile 
would be consistent with the production of an AAC(3)-III or 
AAC(3)-IV enzyme. Enzymes classified as AAC(3)-I do not 
modify kanamycin or neomycin making this an unlikely 
possibility.
Initially S. enteritidis SE-4 was believed to contain a 
gentamicin resistance gene other than aacC2 because the 
pattern of DNA hybridization was different from the AAC (3)-II 
producing strain SE-2. However, gentamicin acetyltransferase 
activity comparable to S. enteritidis SE-2 and C. freundii 
EA-2 was observed, and an aacC2 gene was cloned from this 
strain using the polymerase chain reaction (E. Achberger, 
personal communication) . The different hybridization pattern 
may be the result of different DNA regions flanking the gene. 
Therefore, it appears that a minimum of three different 
gentamicin resistance genes are present within the commercial 
turtle population across southern Louisiana.
CONCLUDING REMARKS
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Initial studies of the presence of Salmonella enteritidis 
on commercial turtle farms, directed by Dr. R.J. Siebeling in 
1974, led to the development of a successful egg sanitation 
procedure involving gentamicin. However, problems incurred 
by the turtle farmers appeared with the emergence of 
gentamicin resistant enteric organisms, including Salmonella 
enteritidis, in the turtle environment.
The project presented here has detailed numerous 
significant findings related to the problem of gentamicin 
resistance within the turtle population. A chromosomally- 
derived Citrobacter freundii gentamicin resistance gene was 
determined to be responsible for a widespread resistance 
mechanism in enteric isolates. The 858 bp aacC2 gene encoded 
a 30,000 Da aminoglycoside acetyltransferase imparting high 
level gentamicin resistance. In the studies reported here, 
neither the drug resistance nor the gentamicin 
acetyltransferase activity were affected by gene dosage or 
strength of promoter upstream of the gene. The expression of 
the resistance gene was not inducible. Based on codon usage 
indices, it is likely that the aacC2 gene was poorly 
translated. Furthermore, the high G+C content suggests that 
the aacC2 gene did not originate in the enteric isolates.
Comparison of nucleotide sequences indicates that our 
aacC2 gene may be closely related to other aacC2 genes which
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have been found in clinical isolates from the Netherlands, 
Czechoslovakia, United States, and Chile (Vliegenthart et 
al., 1989). Although nearly complete DNA homology exists 
among several of these genes, it is highly unlikely that 
they share a recent common source.
Based on Southern hybridization studies, homologous 
genes were detected in several gentamicin resistant 
Citrobacter freundii, Proteus vulgaris, and Salmonella 
enteritidis isolated from various sources on different turtle 
farms. However, there was no detectable homology with the 
chromosomal DNA of several highly resistant strains of 
Salmonella enteritidis. These hybridization data, coupled 
with acetyltransferase activity assays, have revealed 
evidence for a minimum of three different gentamicin 
resistance genes within the turtle population in Louisiana.
Depending on the levels of resistance conferred by these 
genes, the finding of multiple gentamicin resistance genes or 
mechanisms may complicate the problem faced by the turtle 
farmers. The aacC2 gene appears to confer a maximum 
resistance of 100 /xg/ml, and organisms with this level of 
resistance appear to be effectively eliminated during egg 
sanitization. However, if an unidentified gene in the turtle 
population imparts a greater level of resistance, the egg dip 
regimen presently employed may not eliminate resistant 
organisms. As previously mentioned, this problem may become 
compounded by selecting for aminoglycoside resistant
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mutations in isolates that are already highly resistant to 
gentamicin.
Whether the present dip procedure is sufficient to rid 
turtle eggs of Salmonella enteritidis carrying gentamicin 
resistance mechanisms other than the aacC2 gene can be tested 
easily. A representative number of eggs can be infected with 
a predetermined concentration of these resistant S. 
enteritidis by the pressure differential method. These eggs 
can then be divided into groups and treated using the current 
dip regimen. Each group could be treated for a different 
length of time. After incubation and hatching, hatchling 
excretion assays could be performed to determine the number 
of resistant organisms surviving the dip treatment.
The complete eradication of gentamicin resistant 
organisms in the turtle population is not possible at the 
present time. There are, however, several factors which the 
turtle farmers can control that may simplify their problem. 
The presence of Salmonella enteritidis in a representative 
number of eggs from a farming lot will cause all eggs from 
that lot to fail inspection. Therefore, it is recommended 
that farmers keep lots as small as possible. This would 
decrease the numbers of turtles that would have to destroyed 
if the lot fails. Periodic testing of the gentamicin dip 
solution is crucial to the success of the egg treatment. 
Since gentamicin is readily bound by organic material 
introduced with eggs and the dip solution may become diluted 
by impurities, the concentration of gentamicin can drop below
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the required level (i.e., 1000 /xg/ml) . If the dip solution 
is tested, sterilized, filtered and maintained at the 
critical concentration, S. enteritidis should be
successfully eliminated.
Future experiments for the continuation of this project 
may include the cloning of other gentamicin resistance genes, 
particularly from the resistant S. enteritidis which did not 
appear to contain the aacC2 gene. The polymerase chain 
reaction method has been used in the cloning of aacC2 genes 
from several gentamicin resistant organisms (E. Achberger, 
personal communication). It may also facilitate cloning and 
detection of other resistance genes. Other activity assays 
can be used to detect the presence of gentamicin 
phosphotransferases and nucleotidyltransferases. The 
phosphocellulose paper binding assay may provide data for a 
more accurate comparison of the activities conferred by the 
homologous aacC2 genes of C. freundii, P. vulgaris, and S. 
enteritidis.
It would be difficult to determine the initial bacterial 
source of the gentamicin resistance genes in the turtle 
population. Molecular cloning, nucleotide sequencing and 
studies involving possible gene transfer among bacteria may 
facilitate this study.
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APPENDIX A
Calculation of qentamicin acetvltransferase specific 
activity
S = Units/mg protein
where S = specific activity;
Units = nmol gentamicin acetylated per minute at 
room temperature (approximately 25°C); 
mg protein = total mg of protein in cell extract as 
determined using Bio-Rad Protein Assay 
(Bio-Rad Laboratories, Richmond CA);
Calculation of Units
slope X chart speed
Units =
1 3 .6
where slope = the slope of the plot on the chart
recorder; optical density/inch;
chart speed = inches/minute; recorded for each 
assay;
13.6 = the extinction coefficient for DTNB at 
412 nm; nmol/optical density;
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APPENDIX B
Calculation of codon usage index 
A - ± (CJ (Di)
B - L (C L ) (Di)
where X = codon usage index;
A = total number of preferred codons occurring in
given nucleotide sequence; see table, next page;
B = total number of amino acids in the given protein 
minus the number of methionines, tryptophans, 
and cysteines in the given protein;
C = number of preferred codons used for a given
amino acid divided by the total possible codons 
for that amino acid;
D = number of times a given amino acid appears in 
the given protein;
i = given amino acid;
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Comparison of codon usage for Citrobacter freundii EA—2 
aacC2 gene with highly expressed Escherichia coli genes
Amino Acid Codon8 Useb
U) (1) (2) (3)
glycine GGU 27 47 9
GGC 17 44 8
GGA 0 3 6
GGG 0 5 7
alanine GCU 32 23 4
GCC 2 10 12
GCA 17 21 7
GCG 6 31 12
valine GUU 22 35 6
GUC 2 5 8
GUA 10 17 0
GUG 3 19 8
leucine UUA 1 2 1
UUG 1 3 5
CUU 1 6 4
cue 0 7 4
CUA 0 1 1
CUG 3 19 8
isoleucine AUU 2 11 2
AUC 17 67 5
AUA 0 1 3
phenylalanine UUU 2 6 3
UUC 8 25 6
tyrosine UAU 3 5 2
UAC 16 18 7
tryptophan UGG 5 5 4
proline ecu 2 2 4
CCC 0 1 6
CCA 3 3 0
CCG 15 32 8
"Preferred codons in E. coli are underlined 
bFor (1) and (2), numbers indicate the total frequency of 
occurrence of each codon in the following highly expressed 
genes: (1) Ipp, lamB, ompA; (2) tufA, EF-G, IF3, recAj (3)
indicates codon frequency in C. freundii EA-2 aacC2
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Amino Acid Codon8 Use*5
(i> (1) (2) (3)
cysteine UGU 1 5
UGC 2 5
methionine AUG 10 27
serine UCU 8 17
UCC 11 10
UCA 0 2
UCG 0 1
AGU 0 2
AGC 6 9
threonine ACU 15 21
ACC 11 30
ACA 1 5
ACG 1 8
lysine AAA 22 51
AAG 5 23
arginine CGU 14 42
CGC 5 14
CGA 0 1
CGG 0 0
AGA 0 0
AGG 0 0
histidine CAU 2 4
CAC 4 15
aspartate GAU 9 17
GAC 22 40
glutamate GAA 9 69
GAG 4 22
asparagine AAU 1 3
AAC 24 26
glutamine CAA 2 5
CAG 21 31
"Preferred codons in E. coli are underlined 
For (1) and (2), numbers indicate the total frequency of 
occurrence of each codon in the following highly expressed 
genes: (1) lpp, lamB, ompA; (2) tufA, EF-G, IF3, recA; (3) 
indicates codon frequency in C. freundii EA-2 aacC2
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